|Publication number||US5011469 A|
|Application number||US 07/237,969|
|Publication date||30 Apr 1991|
|Filing date||29 Aug 1988|
|Priority date||29 Aug 1988|
|Also published as||CA1325754C, DE8990089U1, EP0357338A2, EP0431071A1, EP0431071A4, WO1990001972A1|
|Publication number||07237969, 237969, US 5011469 A, US 5011469A, US-A-5011469, US5011469 A, US5011469A|
|Inventors||Gerald D. Buckberg, James V. Maloney, Jr., Kenneth A. Jones, Weldon D. West|
|Original Assignee||Shiley, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (2), Non-Patent Citations (7), Referenced by (416), Classifications (18), Legal Events (10)|
|External Links: USPTO, USPTO Assignment, Espacenet|
The subject invention relates to the treatment of heart attacks by placing the patient on a heart/lung machine without the necessity of a conventional open-chest operation, and to the treatment of the heart attack by the infusion of a special solution directly into the coronary arteries supplying the heart muscle.
Each year numerous people suffer a heart attack (acute myocardial infarction) due to the obstruction of a coronary artery which supplies blood to the heart muscle. Of this number, a significant percentage die before reaching medical attention. Another group succumbs after reaching the hospital. Of those which survive, more than half suffer permanent loss of a portion of the heart muscle owing to the damage done during the period of a heart attack by the lack of blood supply (ischemia). This damage impairs the quality of life, shortens life expectancy, and increases the probability of death with subsequent heart attacks.
Currently the methods of treatment of heart attack victims include:
(1) observation and medication in a coronary care unit;
(2) thrombolysis - dissolving by drugs the clot which blocks the coronary artery;
(3) percutaneous coronary angioplasty (PTCA) reopening the obstructed artery with a balloon dilator threaded through the arterial system;
(4) emergency operations for coronary artery bypassdetouring blood around the blockage with a blood vessel graft;
(5) balloon counterpulsation - relieving about 10-15 percent of the work of the heart with a pulsating balloon placed in the body's main artery, usually used as a temporizing measure prior to or during the foregoing methods of treatment; and
(6) assist devices - tubes temporarily left in the heart following a bypass operation where the heart is too weakened to support the circulation, even with the balloon treatment of (5) above.
Despite the best available therapy, a significant percent of the patient's die, and those who are not treated fairly promptly suffer permanent loss of heart muscle supplied by the blocked artery. The primary damage to the heart muscle during a heart attack occurs because of the blood supply to a portion of the heart being interrupted; and therefore, the primary goal of the treatments referred to above has been to restore the blood supply as quickly as possible. However, while some of the methods outlined above have decreased the time required to restore blood flow to the portion of the heart subjected to ischemia, they have not resulted in that heart muscle being able to restore its function to the degree previously hoped. Recent studies show that limitations of previous techniques of reperfusion to restore heart muscle function are due to their inability to control the conditions of reperfusion (for example, the blood pressure, the work of the heart) or the composition of the reperfusate blood. The solution used for this purpose keeps the region of the heart muscle from beating (cardioplegia) to minimize its need for oxygen. The cardioplegic solution contains oxygen because it is mixed with oxygenated blood from the heart/lung machine (blood cardioplegia).
Recent experimental studies have demonstrated that controlled reperfusion, which can be achieved via surgical intervention, may facilitate recovery of the left ventricular function after myocardial infarction to a greater degree than can be achieved using conventional pharmacologic or mechanical strategies. The September 1986 issue of the Journal of Thoracic and Cardiovascular Surgery, entitled "Studies of Controlled Reperfusion After Ischemia," discloses results of laboratory experience supporting the conclusion that controlled reperfusion is necessary. More specifically, it has been determined that damage can be avoided by administering a special blood cardioplegia reperfusate to the damaged area before normal blood flow is resumed. Tests on dogs and other animals indicate that the blood cardioplegia negates the adverse effects of toxins which build up in the myocardium during the ischemia caused by the obstruction of blood to that portion of the heart. The re-introduction of normal blood flow, without the cardioplegia, does not revive the oxygendeprived tissue and results in loss of all or a portion of the affected myocardium. It appears that the cardioplegia solution flushes the damaged capillary bed of toxins that have accumulated during the infarct episode. This cleansing apparently facilitates the recovery of the heart tissue when normal blood flow is resumed. Included in this issue is a preliminary series of patients treated by surgically controlled reperfusion who experienced the same excellent recovery of heart muscle function that occurred under experimental conditions. These results have been confirmed in a recent series of patients who were treated in a multi-center trial of thrombolytic treatment (TAMI) and who did not qualify for or failed the more conventional pharmacologic approach of thrombolysis. The surgical treatment was that of controlled reperfusion following the protocol described in the September 1986 Journal referenced above.
In addition, the studies referred to in the above-mentioned Journal have shown that the foregoing treatment produces good recovery only when the heart is decompressed (left ventricle vented) by extracorporeal circulation. Without such venting during the extracorporeal circulation, there can be sufficient blood returned into the ventricle to cause it to eject, and thereby raise the metabolic demands of the damaged muscle by stretching it.
The studies reported in the above-referenced Journal utilized open-chest techniques for the extracorporeal circulation, with a secondary pump for the venting of the ventricle to obtain the desired decompression condition. However, it is suggested that instead of an open-chest operation, a peripheral bypass technique be employed wherein catheters are connected to the vascular system. With a peripheral technique, catheters may be introduced percutaneously or by using a cutdown procedure along with vessel dilation.
The aforementioned Journal article (page 560) proposes an experimental model of a peripheral (in this case) femoral-to-femoral vented bypass system in humans, together with regional cardioplegia reperfusion, without thoracotomy. This, however, is a desired goal, and the specific manner and apparatus of accomplishing this is not disclosed in detail because it had not been done.
There have been some femoral-to-femoral bypass systems, such as in U.S. Pat. No. 4,540,399, but it is not clear that total bypass is obtained, and there is no provision for ventricular venting.
Summarizing some of the foregoing background, it can be simply stated that: heart attacks are caused by closed coronary arteries; opening an artery does not cure the heart attack; and controlling the conditions and composition of the initial reperfusion of a blocked coronary artery does permit salvage of the damaged myocardium beyond the obstruction. The only accepted way to control the conditions and composition of coronary reperfusion of individuals undergoing a heart attack is by open-chest surgical operation with direct decompression of the heart, decompression of the left ventricle and direct infusion of the coronary arteries through surgically connected saphenous vein grafts. Although the results of this approach have been proven superior to results obtained by any of the current methods of treating acute myocardial infarction, the performance of a major operation has risks of mortality and morbidity, and a high level of expense.
There is thus a clear need for an improved system which will minimize the damage to the myocardium following heart attacks. Such a system should be able to be applied quickly after the onset of symptoms. It should provide for the opening of the blocked artery without permitting normal blood flow to enter the ischemic area. It should permit infusion of a fluid of a specific composition under controlled conditions of temperature, pressure and flow. Further, the system should relieve the workload of the heart by supporting the body on an extracorporeal circulation to eliminate the flow work of the heart and relieve the left ventricle of all blood to eliminate pressure work of the heart. Further, it is highly desirable that the foregoing be accomplished without the risk of a major chest operation in critically ill patients.
It is also desirable that an improved extracorporeal circulation system be available for applications other than in connection with cardioplegia reperfusion.
The invention comprises a unique cardiopulmonary bypass system, method and apparatus, including a venous catheter for insertion into a femoral vein and an arterial cannula for insertion into a femoral artery. An arterial pump and oxygenator are connected between the venous catheter and the arterial cannula to circulate all of the patient's blood. A vent catheter is inserted preferably through a femoral artery and passed backwards through the arterial system to the left ventricle of the heart where it removes bronchial blood and permits complete rest to the ventricle. Preferably, the vent catheter is connected in parallel with the venous catheter and is connected in the same line to the pump. With this arrangement, negative pressure developed by the pump is simultaneously applied to the venous catheter and the vent catheter in a manner such that all of the patient's blood which would normally return to the heart is bypassed through the venous catheter, and the blood reaching the left ventricle of the heart is withdrawn through the vent catheter so that the ventricle is decompressed. This is in contrast to previous techniques of ventricular decompression which have required a separate pump to aspirate blood from the left ventricle.
The venous catheter is of special design which, for the first time, permits the induction of percutaneous total extracorporeal circulation, without producing dangerous increases in negative pressure. The hydrodynamics of the venous catheter system are selected so that they permit full normal cardiac output of 5 to 7 liters per minute without exceeding a maximum negative pressure, or suction, in the range of 140 to 200 mm Hg. This constraint minimizes blood damage and avoids creating bubbles in the blood.
Likewise, the vent catheter is carefully sized to handle the volume needed to ensure that the ventricle remains decompressed while operating within the same upper negative pressure limitation. This volume ranges from 50 to 500 ml per minute. The cardioplegia treatment is effective only if the heart is decompressed completely (total vented bypass). Left ventricular decompression is not possible by arterial and venous cannulation alone, as the venous cannula may fail to collect all of the venous return, and some blood from the lungs may enter the left ventricle via the bronchial veins. Connecting the venous return catheter and the vent catheter conduits in parallel to a single pump facilitates monitoring and maintaining the negative pressure below the maximum permitted.
Preferably, the vent catheter includes a separate lumen for continuous monitoring of ventricular pressure to ascertain that the heart is at rest. The vent catheter is specially designed to be inserted through the aortic valve without injury to the valve or producing insufficiencies by distorting the valve. Also, the pressure lumen inlet is located spaced from the catheter tip so that when the lumen inlet is in the ventricle, the attendant knows the vent catheter holes are in the ventricle.
To accommodate possible fluctuations in the volume of the flow required, and to regulate the blood volume of the patient, a reservoir, preferably compliant, is provided bridging the pump, with an inlet to the reservoir being connected to the pump outlet, and an outlet from the reservoir being connected between the venous catheter connection and the pump. Inflow and outflow valves in the connections permit circulating blood volume and therefore blood flow rates to be controlled.
The arterial catheter employs an angled shoulder which limits insertion of the cannula and provides a seal with the artery. Also, it includes a removable seal which prevents hemorrhage from the femoral artery as the stylet within the cannula is withdrawn.
For use of this system in a heart attack situation, there is provided a blood cardioplegia delivery system having an inlet connected to the output of the arterial pump. The coronary reperfusion catheter connected to the output of the pump is inserted through an artery to reach the area of the heart that has been deprived of blood. The reperfusion catheter traverses a clot in a coronary artery narrowing (stenosis) to allow precise control of the reperfusate blood composition and conditions (i.e., flow and pressure). Cardioplegia solution is then supplied to that area while the bypass system is in operation, including maintaining decompression of the ventricle. Following the cardioplegia application, the normal blood flow may be resumed, and an angioplasty can be performed to relieve the narrowing in the coronary artery.
The femoral-femoral bypass system is particularly versatile in that it can be employed in a cardiac catheterization laboratory, since it does not require an open-chest operation. This is very advantageous in connection with patients who would not likely survive the initiation of anesthesia or the opening of the chest for conventional heart surgery under emergency circumstances. With the system apparatus on a cart, the patient and the system may be transported from the catheterization lab into the operating room for use during open-heart surgery. Previous, less than total bypass, percutaneous systems needed to be discarded when patients were brought to the operating room.
The system is also useful in connection with patients in cardiac shock (providing up to 100% support of the circulation, rather than 15% support as in balloon counterpulsation). The system is also useful for routine extracorporeal circulation situations. The system further advantageously lends itself to electronic and mechanical control systems uniquely designed for performance of total extracorporeal circulation and controlled coronary reperfusion.
FIG. 1 is an overall schematic view of the system of this invention;
FIG. 2 is a schematic, partial sectional view of the heart and venous and arterial passages to the heart.
FIG. 3 is a partial sectional view of a portion of a human heart with a vent catheter and a reperfusion catheter inserted into the heart;
FIG. 4 is a perspective view of a portion of a femoral venous catheter;
FIG. 5 is a cross sectional view on line 5--5 of FIG. 4;
FIG. 6 is a graph illustrating the fluid flow dynamics of the venous catheter and the vent catheter;
FIG. 7 is a perspective view of a portion of a vent catheter used in this invention;
FIG. 8 is a cross section of the vent catheter on line 8--8 of FIG. 7;
FIG. 9 is a schematic illustration of the use of an alternate pumping arrangement;
FIG. 10 is a schematic perspective view of an arterial cannula assembly inserted in the femoral artery;
FIG. 11 is a view similar to FIG. 10, but with a stylet of the cannula assembly partially withdrawn;
FIG. 12 is a perspective view of the cannula assembly of FIGS. 10 and 11;
FIG. 13 is a perspective view of the stylet of the assembly of FIG. 12;
FIG. 14 is a perspective view of an anti-backflow ring of the cannula assembly;
FIG. 15 is an enlarged, perspective, schematic view of the cannula assembly inserted in a femoral artery;
FIG. 16 is a side elevational, partially sectionalized view of the assembly of FIG. 12;
FIG. 17 is a cross-sectional view of the cannula assembly with the stylet partially withdrawn and with the cannula clamped to prevent flow therethrough;
FIG. 18 is a cross-sectional view on line 18--18 of FIG. 16; and
FIG. 19 is a perspective view of the detail end of the reperfusion catheter assembly.
By way of a brief overview the system will be described in connection with FIGS. 1, 2 and 3, as applied to a recent heart attack victim. A femoral-femoral bypass is performed wherein a femoral venous catheter 10 allows right heart access via the femoral vein 11. A femoral arterial cannula 12 allows the return of oxygenated blood to the femoral artery, and is used in connection with the venous catheter 10 to achieve femoral-femoral total extracorporeal circulation.
A left ventricular vent catheter 14 is used to vent the left heart during extracorporeal circulation with the introduction of the catheter 14 made at the femoral artery and passing transaortically into the left ventricle. A coronary reperfusion catheter 16 is inserted into, and transverses a stenosed vessel in order to reperfuse the heart region beyond the stenosis.
The venous catheter 10 and the vent catheter 14 are in fluid communication with an arterial pump 18 which provides a negative pressure in order to draw venous blood into the arterial pump and to draw blood out of the left ventricle, and maintain that portion of the heart in an at rest condition. The arterial pump 18 forces the blood through an oxygenator/heat exchange 20 and an arterial filter 22. A heater/circulator 21 provides fluid flowing into the heat exchanger contained within the oxygenator 20.
A bridging venous reservoir 25 is connected in fluid communication with both the arterial pump 18 and the membrane oxygenator 20 in order to prime the system and to maintain sufficient fluid for proper operation. A cardioplegia delivery pump 24 is in fluid communication with the oxygenated blood after it leaves the arterial filter 22, and is also in fluid communication with a cardioplegia source 26 so as to mix the oxygenated blood and cardioplegia before delivering it at a predetermined flow rate to the coronary reperfusion catheter 16.
The vent catheter 14 removes all residual blood from the left ventricle and enables the heart to maintain an at-rest condition while the reperfusion catheter 16 enables reperfusion of the heart region beyond the stenosis which precipitated the heart attack.
In more detail, the femoral venous catheter 10 is preferably made from ethylene-vinyl-acetate (EVA) tubing, preferably having about 18% acetate. The tubing has a constant inner diameter from the insertion tip up to the proximal end. The proximal end of the catheter 10 connects to a 3/8-inch connector which is in fluid communication with the arterial pump. The catheter 10 should be long enough to reach the right atrium from the femoral triangle. An intravascular length about 70 cm, and an overall length of about 85 cm, has been found to be suitable. The thin wall and flexibility of the catheter allow for its introduction percutaneously into the femoral vein of a wide range of patients, and resist the kinking that might otherwise occur with other thin wall catheters as they are advanced through the iliac veins and across the curve of the pelvis.
The distal end 27 of the venous catheter lo, as seen in FIGS. 4 and 5, has a plurality of drainage holes 28 which in a prototype product have a diameter of 0.165 with 1/4-inch center to center spacing. These holes have smooth edges and are formed by a tubular cutter, with the catheter internally supported on a mandrel. The holes are arranged in a spiral pattern so that if some holes are blocked by vessel walls, others will be open. This arrangement also minimizes weakening of the catheter while providing the necessary hole area. The holes extend sufficiently far from the distal end of the catheter to span the area from which blood is to be withdrawn. The preferred technique for introducing this cannula into the body is to use the Seldinger technique (percutaneous) or a cutdown procedure along with vessel dilation. A radiopaque tip marker 25 near the distal end enables the drainage holes to be oriented in the superior vena cavae. An elongated removable stylet 31 which receives a 0.045 inch guidewire (not shown) is used to introduce and guide the catheter into position.
The cross-sectional size and the material of the catheter 10 is particularly critical. Since a total bypass system is needed to accomplish the goals of the invention, it is necessary that the venous catheter fit within various constraints. Bypassing the patient's total blood flow requires a capacity in the range of up to 5-7 liters per minute. An overall flow rate of 5 liters per minute is expected in most patients. A thin-walled construction is advantageously used to provide a larger blood flow within the size limitations that may be accommodated by human veins. The EVA material, in connection with the thin-walled construction, provides the needed flexibility to be properly positioned, yet sufficient strength to prevent kinking during normal handling. Moreover, the characteristics of the material are such that if the tubing is kinked and then released, it is self-restoring without significant weakening.
It has been determined that a negative pressure of 200 mm of mercury is an appropriate safe maximum. Higher levels of negative pressure, which could create greater blood flow, run the increasing risk of creating bubbles in the blood. Although a minimum wall thickness is desired, the tubing must not collapse when subjected to such negative pressure. It has been determined that a catheter size of 26 French (O.D. - 0.341 inch, 8.66 mm) is suitable. Preferably, the catheter has an inner diameter of 0.277 inch (7.03 mm), thus making a wall thickness of 0.032 inch (0.825 mm). An alternative approach is to use two smaller venous catheters that will carry the flow at the same negative pressure.
FIG. 6 illustrates the constraints of the venous catheter construction graphically from test data. It can be seen that the fluid flow dynamics are such that significant negative pressure is needed to approach the required flow rates, but yet the increased flow from increased suction diminishes quickly at higher levels, particularly for the smaller lumens. Within the acceptable pressure limit, it can be seen that inadequate flow is obtained from a 22F or 24F (French) thin-walled lumen. A 29 French thin-walled size provides adequate flow, but is too large for the vein of some patients, and produces insufficient negative pressure to assist vent drainage optimally (as discussed below). Incidentally, the 29 French lumen was made of polyethylene rather than EVA. It is believed that the flow curve would be similar for EVA. The 26 French size provides adequate flow within an acceptable pressure range of about 100-200 mm Hg, and it can be accommodated by the femoral vein of most adults.
Referring to FIGS. 7 and 8, the vent catheter 14 is preferably a size 12.5 French (0.164 inch, 4.166 mm O.D.) (0.120 inch, 3.04 mm I.D.). The catheter is preferably made from a flexible polyvinyl chloride (PVC) tubing. The distal end 30 is formed in a loop providing a so-called "pigtail." This loop, when unstressed, has an outside diameter of about 7/8-inch, and has a plurality of spaced apertures 32 which are preferably about 0.050 inch in diameter and extend over a vent length of about 4 cm. A series of apertures 32 are located on opposite sides of the catheter.
The catheter 14 must be long enough to reach the left ventricle from the femoral triangle when passed retrograde through the arterial system. A catheter with an intravascular length of 100 cm, and an overall length of about 112 cm is preferred.
As seen from FIG. 8, the catheter 14 includes a pressure monitoring lumen 41 which is integral with and formed in a wall of the vent catheter 14. Preferably, this lumen 41 has a diameter of about 0.030 inch. The lumen 41 extends from the proximal end of the catheter 14 to a pressure inlet 41a which is spaced from the catheter tip a distance further from the tip than the apertures 32. The inlet 41a is positioned about 4 inches from the distal end of the catheter. The inlet 41a is located on the same side of the catheter 14 as the pigtail to prevent obstruction of the inlet 41a when the catheter contacts the ventricular wall.
Preferably, the catheter 14 is extruded with the lumen 41 extending throughout the length of the tubing. After the apertures 32 are formed, the distal end of the tubing is heated and stretched to reduce its diameter and increase flexibility, and to form the pigtail into its curled shape. In the stretching and heating operation, the lumen 41 is closed on the distal end of the catheter. The opening 41a is formed by cutting the tubing at the desired location spaced further from the tip than the apertures 32.
In the stretching of the distal end, the exterior diameter of the catheter is decreased from 0.164 inch to about 0.100 inch, and the interior diameter is decreased from 0.120 inch to 0.062 inch. The very tip of the catheter is reduced a slight amount further. That is, the tip 0.030 inch is tapered on its exterior and is reduced on its interior diameter to about 0.040 inch.
The preferred method of introducing the vent catheter 14 into the femoral artery is by using a sheath introducer procedure. After a tubular sheath (not shown) is positioned in the entrance to the artery, a guidewire 47 is introduced into a stiffening stylet (now shown) that is in the flow lumen of the catheter. The guidewire extends beyond the pigtail distal end 30 sufficiently to straighten it and to permit insertion. The assembly is then inserted through the sheath into the artery. The guidewire and stylet are stopped when the wire approaches the aortic valve. The guide wire and the stylet are then withdrawn approximately 10 cm. As the guide wire and stylet are withdrawn past the distal tip, the pigtail recurls, due to its memory, into the position shown in FIG. 7. Thus, the curled distal end resiliently engages the aortic valve and passes through the valve without trauma when the valve opens. The distal end then assumes the position illustrated in FIG. 2 wherein the pressure lumen hole 41a in the distal end is shielded from the ventricle walls so as to prevent blockage when pressure is monitored through the catheter. The flexibility of the catheter permits its presence in the ventricle, across the aortic valve, without causing distortion of the cusps of that valve and therefore avoids aortic insufficiency.
A tube 40 is in fluid communication with the proximal end of the vent catheter via one aperture in a Wye connector 38 with the tube also communicating with the arterial pump 18. The catheter 14 is sized to allow transmission of approximately up to 500 ml per minute of blood flow at the same negative pressure at which the catheter 11 is operated by the arterial pump 18. A pressure transducer is connected to a second aperture in the Wye connector 38 which in turn is connected to the second lumen 41. Thus, the lumen 41 monitors the pressure in the left ventricle directly. If the ventricle is being properly decompressed, the sensed pressure should be about zero. Thus, there is a significant difference in pressure on the opposite sides of the aortic valve. This can be observed on a pressure monitoring instrument by moving the catheter so that the pressure lumen inlet 41a is exposed to either ventricular pressure or arterial pressure. The location of the inlet 41a is important in that, if the pressure is at the ventricular levels, ejecting or decompressed, it is known that the vent apertures 32 are in the ventricle.
The vent catheter is, as noted, necessary to ensure the left ventricle is completely decompressed, and does not fill with fluid and cause the heart to eject (pump), even though the heart is being bypassed. The venous drain cannula 10 does not ensure continual left ventricle decompression. Some coronary sinus return and/or bronchial flow will enter the left ventricle, distend it, allow wall tension to develop and result in occasional ejection despite apparent right heart decompression from the venous catheter 10. Thus, it is important that the catheter and its connecting tube 40 are sized to transmit the maximum anticipated flow from the left ventricle. This can range from 50 to 500 ml. Further, it is necessary to restrict negative pressure to the 200 mm Hg limitation mentioned above in connection with the venous catheter.
With reference to FIG. 6, the relationship between applied negative pressure (ordinate) and venous cannula flow (lower abscissa) and vent catheter flow (upper abscissa) is presented. Note: (a) The venous flows of 5 to 7LPM are achieved at negative pressures of less than 200 mm Hg only with EVA catheters #26 and #29 French. (b) The 12.5 French vent catheter always drains 7 percent of venous flow, the maximum expected flow from the left ventricle at venous flows of 5 to 7LPM.
FIG. 6 also illustrates the constraints of tubing size and pressure for the vent catheter identified as 12.5F vent on the graph. The curve for the vent catheter shows a vent flow capacity of about 100 ml/minute at a very flow negative pressure, and up to 500 ml/minute at about 175 negative pressure. This is a very satisfactory pressure limit for providing the desired vent flow capacity. As shown in FIG. 1, the suction provided by the venous catheter 10 and the ventricular vent catheter 14 are both advantageously provided by the same arterial pump. The diameter and flow resistance of the tubes 29, 40 and the catheters 10, 14 are selected with a diameter and length to provide a predetermined ratio of flow from each of the catheters for a given suction by the pump. Thus, the amount of suction provided to the left ventricle by the vent catheter 14 will vary in a predetermined relationship with respect to the blood withdrawn from the femoral vein by the venous catheter. While a separate pump can be employed for the vent catheter, as in the prior art, it is highly desirable that the single pump approach be employed. To accomplish this, it is necessary to balance and coordinate those two catheters. That is, it is necessary to utilize a vent catheter that provides the needed flow within the pressure constraints required in connection with the venous flow. Thus, the amount of suction provided to the left ventricle by the vent catheter will vary in a predetermined relationship with respect to the blood withdrawn from the femoral vein by the venous catheter. As seen, the curve for the vent catheter is very similar to that for the 26 French venous catheter in the flow range desired. Thus, if there is a need for change of flow in either catheter, the flow through the other catheter will be satisfactory. With the above specified flow rates, the flow rate of the venous catheter 10 will be, in a preferred construction, about 14 times greater than the flow capacity in the vent catheter 14 for the same negative pressure, but may range from 10 to 50 times greater for tubes of different sizes.
If, in monitoring the pressure in the ventricle, it is observed that the pressure is becoming too high, indicating an accumulation of blood, pump speed can be increased to increase the flow through the vent catheter and the venous catheter, so long as the maximum negative pressure of 200 mm Hg is not exceeded. Thus, for example, if the ventricle pressure should start to climb with vent flow at 360 ml and venous flow at 51, pump speed can be increased to provide 500 ml of vent flow capacity, venous flow only increasing to 7 liter a minute, and the negative pressure is at a safe 180. A venous pressure transducer 42 monitors the pressure in the tubes 29 and 40 generated by the arterial pump 18.
A ventricular vent catheter of the type described above is also useful for reducing volume of the ventricle in partial bypass situations, i.e., when not using a venous catheter and an oxygenator. In such situations a larger catheter is desired, such as 18 French. The inlet holes 32 may also be enlarged to accommodate increased blood flow. Possibly with a larger catheter yet, a 100% assist can be attained.
The bridging reservoir 25 is connected in parallel with the arterial pump 18, with flow clamp 44 between the reservoir and the pump inlet, and a flow clamp 46 between the pump outlet and the reservoir. With this arrangement wherein the flow is not through the reservoir, the volume in the circuit can be controlled by temporarily opening one or the other of the clamps. If more volume is needed, the clamp 44 is briefly opened and then closed when the volume is at the desired level. Similarly, if less volume in the circuit is desired, the clamp 46 is briefly opened until the desired volume is attained.
The system and method of this invention is a closed system; the chest is not opened to access the heart and there is no blood-to-air interface (other than in the oxygenator 20). Thus, whatever blood is taken out of the body must be returned to the body via catheter 12. The bridging reservoir 25 facilitates circulatory stability during the initiation and conduct of the bypass by providing volume control. Maintaining a stable fluid flow in the body is especially important during the time immediately following the initiation of extracorporeal circulation, as such instability can cause severe hypotension, possibly exacerbate the infarction, and cause secondary arrhythmias or cerebral symptoms. The reservoir provides sufficient fluid to maintain circulatory stability and has the capacity to allow fluid removal if the patient's blood volume is excessive due to heart failure. Further, the fluid in the reservoir can be used to prime the system.
The arterial pump 18 withdraws blood from the body under a negative pressure (suction), along with the appropriate amount of fluid from the reservoir 25, if any is needed, and pumps the blood and fluid mixture out of the pump under a positive pressure. The arterial pump 18 is schematically illustrated in FIG. 1 as a centrifugal pump. Such a pump is known in the art and hence is not described in detail herein. One suitable centrifugal pump is that provided by Biomedicus of Minneapolis, Minn. A primary advantage of a centrifugal pump is that it has "hydrodynamic slippage" such that if the patient's blood volume falls, the blood flow diminishes without producing high negative pressures and creating nucleation ("boiling") of gases as might occur with a displacement pump. The pump is connected to an electronic controller to prevent negative pressure from going above 200 mm Hg.
From the pump 18, the blood is forced under pressure to the oxygenator 20 where the blood is oxygenated and the temperature of the blood is controlled. The oxygenator 20 and heater circulator are known in the art and are not described in detail herein.
From the blood oxygenator, the blood is preferably forced through an arterial filter 22, although a bypass is provided. After leaving the arterial filter 22, the main portion of the oxygenated and filtered blood is directed to the arterial cannula 12 where it is returned to the femoral artery of the body.
A bubble detector 50 and an arterial pressure transducer 52 may be located on the tube carrying the blood to the arterial cannula 12.
In lieu of aspirating blood through the venous catheter with a centrifugal pump, a positive displacement pump may be attached to the venous line with an interposed compliance chamber (to dampen phasic pressure variations) such that a servo based on negative pressure in the venous line achieves the desired flow. Such a system is schematically illustrated in FIG. 9. A venous drainage line 129, and a vent catheter line 140, comparable to the lines 29 and 40 in FIG. 1, are joined at a Y-connection to a common line 141 leading to a compliance chamber 143. This chamber is in turn connected by tubing 145 to a positive displacement pump 118 schematically illustrated as a peristaltic pump. A suitable example of a peristaltic pump is made by Stockert/Shiley, in Munich, Germany. The pump 118 is controlled by an electronic controller 119 which receives pressure feedback from the compliance chamber through a suitable pressure transducer connection 121.
The balance of the system of FIG. 9 is comparable to that shown in FIG. 1. A reservoir 25 with inlet and outlet controls 144 and 146 bridges the pump 118 to provide for volume adjustment. The output of the pump is directed through an oxygenator 120, and optionally a filter 122 to a line 123 leading to an arterial cannula. A portion of the oxygenator output is directed through a line 129 to a cardioplegia pump 124 and conducted through a line 125 to a coronary artery by a suitable perfusion catheter. A cardioplegia supply 126 is connected by a line 127 to the pump 124.
The compliance chamber 143 includes a flexible bladder or reservoir 151, having an inlet connected on one end to the venous drainage line 147 and an outlet connected on its other end to pump inlet tube 145. A rigid outer housing 153 encloses the bladder 151. This housing is sealed around the bladder 151 so that the negative pressure applied to the bladder 151 by the pump 118 is also applied to the space within the housing 153 surrounding the bladder 151. This negative pressure within the housing 153 is, as indicated above, sensed by a transducer 155 and fed back to the controller 119. A valved outlet 157 from the housing 153 is opened to atmosphere during priming to allow the bladder to initially expand due to the head pressure of the fluid in the system. The valve is then closed so that any changes in the size of the bladder are then reflected in pressure changes in housing.
The peristaltic pump 118 is desirable in that the pumping mechanism does not actually contact the blood, thus eliminating a source of contamination and allowing reuse of the pump. Its shortcoming, however, is that if the blood supply falls, the pump can quickly increase the negative pressure applied on the venous drainage line to unsafe levels, even with a pressure sensor in the line to send a signal to a controller, the negative pressure can rise undesirably before the pump speed reacts to reduce pressure. The compliance chamber 143 in combination with a sensor and the pump controller solves this problem. The pressure within the rigid housing 153, being the same as that within the flexible bladder 151, is continually sensed and fed back to the pump controller. Thus, if there is a sudden loss of blood which would result in an increase in negative pressure, the bladder will contract to reduce the rate of the negative pressure rise, giving the controller 119 and the pump time to reduce the speed of the pump 118.
As another variation, the housing 153 can be configured to replace the bridging reservoir 125, including being provided with the necessary inlet and outlet valves or clamps. Similarly, venous return can be augmented by negative pressure applied to the space between the housing 153 and the reservoir 151.
A portion of the oxygenated blood through the arterial filter 22 is directed to the cardioplegia delivery pump 24. A cardioplegia solution from a cardioplegia source 26 is mixed with the blood and provided under a controlled temperature and pressure to the coronary reperfusion catheter 16. A normal body temperature of 37° Celsius is believed suitable for the reperfused solution. A suitable cardioplegia solution is believed to be an aspartateglutamate-enriched, hypocalcemia, buffered, hypersomolar blood solution, as discussed more particularly in the above-mentioned Journal, Thoracic Cardiovascular Surgery, September 1986.
A reperfusion pressure transducer 54 and monitor/pump feedback helps regulate the pressure with which the cardioplegia solution is provided to the catheter 16. A flow rate of 50 ml/min or that rate obtained with 50 mm Hg over the pressure drop in the system, whichever is greater, is believed suitable for the reperfusion. Thus, flow is reduced if the pressure exceeds 50 mm Hg, but the rate is best at 50 ml/min if the pressure drops below 50 mm Hg. Further information regarding reperfusion flow rate may be found in Article XVI in the above-mentioned journal. The various pressure transducers 42, 52, 54 and the bubble detector 50 all electronically communicate with a system controller 56, which in turn monitors the vital signs of the heart attack victim and regulates the amount of fluid withdrawn from, and reintroduced to, the victim.
The femoral arterial cannula 12 is, as shown in FIG. 12, a component of a cannula assembly 65. The assembly further includes a stylet 66, which is slidably received within the cannula, a fitting 68 secured to the proximal end of the cannula, a stopcock 70 on the fitting, and a clamp 71. The cannula 12 which is disclosed in detail in FIGS. 10-18 and below is separately claimed in a copending application since it is useful in systems other than that illustrated in FIG. 1.
The cannula 12 comprises an elongated tubular body 72 preferably made from a medical-grade silicone rubber or a polyvinyl chloride material. The body 72 has three primary sections including a distal tip section 72a for insertion into the femoral artery, an intermediate section 72b adapted to extend from the artery to a raised suture stabilizing ring 72c to be located near the exterior skin of the leg, and an exterior section 72d extending from the suture ring 72c to the fitting 68.
The tip of section 72a is tapered to facilitate insertion into an artery. In a preproduction version of the cannula, the exterior diameter of the tip section 72a is 6.68 mm or 20 French, and the interior diameter is 5.08 mm. The intravascular length of the tip section 72a in a preproduction version is 5.88 cm, which is a desirable length to ensure adequate seating within the artery.
The intermediate section 72b has a length of about 5 cm, with an interior diameter that tapers to about 9.27 mm, and with an exterior diameter which tapers from the tip end of about 8.4 mm and increases to about 12-13 cm. Thus, it can be seen that there is a significant exterior diameter change from the tip section 72a to the tip end of the intermediate section 72b. This diameter change forms an annular shoulder 72e adapted to engage the exterior of an artery. That shoulder is formed at an angle of approximately 45° with respect to a diametrical plane through the cannula. It has been found that this angle is particularly desirable for sealing with the exterior of the femoral artery when the cannula is inserted in the direction towards the heart.
Due to the angled shoulder and the angle at which the cannula tip is inserted in the femoral artery, it is important the cannula be rotationally oriented properly. Thus, for orientation purposes, there is formed an elongated orientation rib 72g on the exterior of sections 72b and 72d extending from the suture ring 72c to the proximal end of the body which mates with the fitting 68. The section 72d is about 19 cm in length, making the overall length of the cannula about 33 cm. The interior and exterior diameters are constant with the end of section 72b.
A pair of suture wings or flaps 74 are formed integral with and extend outwardly from the cannula exterior section 72d. The wings have a lower surface which is approximately tangent with the exterior of the section 72d. The suture wings in a prototype are positioned about 5 cm from the suture ring 72c.
Referring to FIGS. 12 and 13, the stylet 66 is an elongated flexible tubular element preferably made of polyvinyl chloride. The stylet 66 is slightly longer than the cannula 12 having a tapered tip 66a on one end which extends beyond the tip of the cannula when the stylet is fully inserted therein. The overall length is about 42 cm. A knob 76 on the other end of the stylet extends beyond the fitting 68 and is useful for installing and removing the stylet from the cannula. The diameter of the stylet is slightly smaller than the inner diameter of the tip of the cannula. A small diameter lumen 77 is formed throughout the length of the stylet and is adapted to receive a small diameter guidewire. Included on the stylet 66 is a cylindrical stop 66b having an exterior diameter which is sized to slide relatively easily within the cannula, but nevertheless there is resistance to movement caused by the stop 76b engaging the interior of the cannula. The stop 76b is spaced from the tip end of the stylet about 15 cm and has a length of about 4 cm. This means that the end of the stop 76b closest to the tip 66a of the stylet is located at the suture ring of the cannula when the stylet is fully inserted in the cannula, as seen in FIG. 16.
Also included in the cannula assembly is an antibackflow ring 80 preferably made of medical-grade silicone rubber. The ring has a short barrel-like tubular shape with two axially spaced outwardly extending annular ribs 80a and 80b. The ribs are dimensioned such that they snugly engage the interior wall of the fitting 68 or cannula 12 and the exterior of the stylet to form a liquid inner and outer seal.
Mounted on the exterior of the cannula between the suture wings and the fitting 68 is the adjustable medical clamp 71. The clamp is of standard construction, adapted to be manually set to pinch the cannula closed when the stylet is removed.
In use, the guidewire is inserted into the femoral artery followed by the cannula and stylet with the stylet fully inserted, as shown in FIGS. 10, 11 and 15. The cannula is preferably introduced by use of the Seldinger technique, or a cutdown procedure along with vessel dilation. The assembly, guided by the guidewire, is inserted to the point where the cannula angled shoulder 72e engages the exterior of an artery 82 with the cannula tip section 72a extending into the artery, together with the tip of the stylet, as illustrated in FIG. 15. It can be seen from that figure that the angled shoulder 72e engages the artery in a manner such that the artery substantially conforms to the shoulder with the exterior of the artery to form a seal, and limits insertion. With the cannula so positioned, it is sutured to the leg by means of the wings, as shown in FIG. 15.
With the cannula so positioned, there is little blood leakage through the hole in the artery as a result of the seal with the shoulder 72e. Also, the backflow ring 80 prevents leakage through the annular passage between the stylet and the cannula, as seen in FIG. 10. With the forward portion of the cannula relatively firmly positioned on the patient's leg, the other end of the cannula is free to be raised or manipulated, as may be appreciated from FIGS. 10 and 11.
When it is desirable to connect the cannula to an extracorporeal circuit, the stylet 66 is partially withdrawn by pulling on the knob 76 to the position shown in FIG. 17, wherein the stop 66b on the stylet engages anti-backflow ring 80 in the fitting. There is firm resistance to withdrawing the ring 80 out of the cannula so that an operator recognizes that is the point to stop. The tip 66a of the stylet is spaced considerably from the suture ring since the length of the stylet from the stop 66b to its tip 66a is somewhat less than the length of the cannula from its fitting end to the suture ring 72c. As the stylet 66 is withdrawn, a small quantity of blood enters the cannula, limited by the volume displaced by the stylet. With the stylet stop engaging the ring 80, the clamp 71 is squeezed onto the cannula section 72d at a location between the tip 66a of the stylet and the suture ring 72c, as seen in FIG. 17. By locating the clamp close to the tip 66a of the stylet, there is only a small quantity of blood between the clamp and the stylet stop. Once the clamp has been positioned, and closed, the stylet can be withdrawn completely with a pulling force greater than that to previously move the stylet, such that the ring 80 in the end of the fitting is also withdrawn. The ring 80 remains captured on the stylet 66. At this stage, there is only a small quantity of blood in the open end of the cannula, and it is not under pressure. Because of this and the suture wings, the end of the cannula can be easily handled for making connections to the pump and priming this cannula without loss of blood.
The reperfusion catheter 16 is preferably made from flexible polyvinylchloride (PVC) tubing, preferably in the range of 3.5 to 5 French. The catheter 16 include a female luer lock fitting (not shown) at the proximal end. Preferably, the PVC tubing is barium impregnated or incorporates two radiopaque bands for locating purposes, one of such bands being located at 61 in FIG. 19. The reperfusion catheter 16 has a distal end 58 which contains a plurality of apertures 60 oriented in a spiral along the longitudinal axis of the catheter 16. The holes are about 0.030 inch (0.762 mm) and extend for a tip length of about 2 cm. The tip of the catheter 16 tapers to a reduced size of about 3 French (0.039 inch, 0.91 mm).
In installing the coronary reperfusion catheter 16, there is first inserted a flexible guidewire 34, such as 0.018 inch diameter, which is capable of being inserted through the occlusion in the heart. A guiding catheter 62 is inserted onto the guidewire 34 to a point just short of the coronary ostium. The catheter 16 is inserted onto the guidewire 34 and into the guide catheter 62. Once the smaller reperfusion catheter 16 is positioned with its distal end 58 beyond the occlusion, the guidewire 34 is withdrawn, and the reperfusion solution can be passed through the catheter 16 to exit through the apertures 60. The tapered tip of the catheter facilitates penetration of the blockage and forms a seal with the blockage to prevent blood flow through the occlusion.
The application of the above system and method will now be described with respect to FIG. 1. A heart attack victim has a heart/lung bypass initiated by cannulating the femoral artery by arterial cannula 12 for arterial inflow, and by cannulating the femoral vein by the venous catheter 10 and advancing it under fluoroscopic control into the right atrium for venous return. The femoral-femoral bypass is sustained by the above-identified apparatus.
The left ventricular vent catheter 14 is inserted through the femoral artery through the aortic valve, and into the left ventricle to provide left ventricular decompression. The vent catheter 14 maintains the heart in an at-rest condition by removing all blood flowing into the left ventricle. The process of the heart attack has been slowed markedly by placing the heart in such at-rest condition.
The reperfusion catheter 16 is inserted as outlined above to administer a regional blood cardioplegia distal to the site of the occlusion which precipitated the heart attack. After reperfusion therapy, the occlusion which caused the heart attack is then dissolved by thrombolytic agents or by balloon angioplasty. The reperfusion catheter 16 or the guide catheter 62 may advantageously be used for these methods of removing the occlusion. Once the reperfusion is completed, a guidewire is reinserted through it and the reperfusion catheter 16 is removed. An angioplasty catheter is then advanced in the guide catheter and conventional angioplasty is performed to relieve the stenosis in the coronary artery which caused a clot to form. The guidewire, angioplasty catheter are removed and, after an additional 30 minutes on total bypass the catheter 14 is withdrawn. The catheters 14, 16 are withdrawn and blood is allowed to enter the left ventricle. The patient can then be taken off the heart bypass system. If the closed artery cannot be penetrated, the patient can be transported to the operating room for coronary bypass grafting around the blockage.
The above procedure, whereby normal blood is excluded from the area of the injured myocardium until after a period of reperfusion, has been shown in animal tests to lead to the consistent recovery of 40-100% of the muscle function when the treatment is given within four to six hours of the occlusion.
The apparatus and procedure thus offer the possibility of allowing greatly improved, if not complete, recovery by heart attack victims who would otherwise suffer from reduced heart function and shortened life span because a portion of the myocardium necrosed from the prolonged absence of blood.
Another advantage is provided by the use of one pump for both the venous catheter 10 and the vent catheter 14. The single pump greatly simplifies the system operation, and requires less personnel, with less training, to maintain the appropriate blood pressure in the heart attack victim, while adequately venting the heart.
The system further advantageously lends itself to electronic and mechanical control systems uniquely designed for performance of total extracorporeal circulation and controlled coronary reperfusion.
While the above description is of the preferred embodiment, the disclosure will suggest or render apparent various modifications and variations to those skilled in the art which are within the spirit and scope of the subject invention.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3513845 *||15 Sep 1966||26 May 1970||United Aircraft Corp||Bypass heart pump and oxygenator system|
|US4546399 *||8 Mar 1984||8 Oct 1985||Olympus Optical Company Limited||Tape recorder|
|1||"Regional Blood Cardioplegic Reperfusion During Total Vented by Pass Without Thoracotomy: A New Concept", Okamoto M. D. et al., Journal Thoracic and Cardiovascular Surgery, Sep., 1986 pp. 553-563.|
|2||*||Copy of Front Page and Page 150 of Manual on Artificial Organs, vol. II, The Oxygenator, Yukihiko Nose, M. D., Ph. D.|
|3||*||Copy of Front Page and pp. 298 and 299 of Artificial Lungs for Acute Respiratory Failure, Theory and Practice.|
|4||*||Pp. 23 27 of Article Entitled A New Method of Para Corporeal Left Ventriculo Aortic Bypass .|
|5||Pp. 23-27 of Article Entitled "A New Method of Para-Corporeal Left Ventriculo-Aortic Bypass".|
|6||*||Regional Blood Cardioplegic Reperfusion During Total Vented by Pass Without Thoracotomy: A New Concept , Okamoto M. D. et al., Journal Thoracic and Cardiovascular Surgery, Sep., 1986 pp. 553 563.|
|7||*||The Journal of Thoracic and Cardiovascular Surgery, Sep. 1986.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US5186713 *||1 Nov 1990||16 Feb 1993||Baxter International Inc.||Extracorporeal blood oxygenation system and method for providing hemoperfusion during transluminal balloon angioplasty procedures|
|US5221257 *||26 Apr 1991||22 Jun 1993||Research Industries Corporation||Apparatus and method for femoral venous cannulation|
|US5269752 *||12 Sep 1991||14 Dec 1993||Bennett Laurence M||Method of extracorporeal treatment using a kink resistant catheter|
|US5308320 *||28 Dec 1990||3 May 1994||University Of Pittsburgh Of The Commonwealth System Of Higher Education||Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method|
|US5383854 *||19 Aug 1992||24 Jan 1995||University Of Pittsburgh Of The Commonwealth System Of Higher Education||Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method|
|US5409461 *||28 Sep 1993||25 Apr 1995||Becton Dickinson And Company||Catheter introducer assembly with needle shielding device|
|US5433700 *||30 Nov 1993||18 Jul 1995||Stanford Surgical Technologies, Inc.||Method for intraluminally inducing cardioplegic arrest and catheter for use therein|
|US5449342 *||23 Dec 1993||12 Sep 1995||Nippon Zeon Co., Ltd.||Apparatus for assisting blood circulation|
|US5451207 *||25 Apr 1994||19 Sep 1995||The Regents Of The University Of California||Method of coronary plaque removal with bypass and perfusion|
|US5452733 *||22 Feb 1993||26 Sep 1995||Stanford Surgical Technologies, Inc.||Methods for performing thoracoscopic coronary artery bypass|
|US5458574 *||16 Mar 1994||17 Oct 1995||Heartport, Inc.||System for performing a cardiac procedure|
|US5462524 *||8 Jul 1993||31 Oct 1995||Research Corporation Technologies||Methods for improving recovery of heart function from open heart surgery|
|US5466216 *||11 Apr 1994||14 Nov 1995||Gish Biomedical, Inc.||Antegrade/retrograde cardioplegia method and system|
|US5540841 *||26 Jul 1993||30 Jul 1996||Pall Corporation||Cardioplegia filter and method for processing cardioplegia fluid|
|US5558644 *||12 Jan 1995||24 Sep 1996||Heartport, Inc.||Retrograde delivery catheter and method for inducing cardioplegic arrest|
|US5584803 *||28 Jul 1994||17 Dec 1996||Heartport, Inc.||System for cardiac procedures|
|US5605545 *||5 May 1994||25 Feb 1997||Northgate Technologies Incorporated||Tubing system for delivering fluid to a surgical site|
|US5630798 *||7 Jun 1995||20 May 1997||Smith & Nephew Dyonics Inc.||Fluid management system|
|US5630799 *||9 Nov 1995||20 May 1997||Smith & Nephew Dyonics Inc.||Fluid management system|
|US5643203 *||7 Jun 1995||1 Jul 1997||Smith & Nephew Dyonics Inc.||Fluid management system|
|US5643302 *||7 Jun 1995||1 Jul 1997||Smith & Nephew Dyonics Inc.||Fluid management system|
|US5662611 *||7 Jun 1995||2 Sep 1997||Smith & Nephew Dyonics Inc.||Fluid management system|
|US5682906 *||5 Jun 1995||4 Nov 1997||Heartport, Inc.||Methods of performing intracardiac procedures on an arrested heart|
|US5695457 *||7 Dec 1994||9 Dec 1997||Heartport, Inc.||Cardioplegia catheter system|
|US5702358 *||23 Feb 1995||30 Dec 1997||Sorin Biomedical Inc.||Cardioplegia delivery apparatus and method of use|
|US5702368 *||30 May 1995||30 Dec 1997||Heartport, Inc.||System for cardiac procedures|
|US5713951 *||5 Jun 1995||3 Feb 1998||Heartport, Inc.||Thoracoscopic valve prosthesis delivery device|
|US5718725 *||5 Jun 1995||17 Feb 1998||Heartport, Inc.||Devices and methods for intracardiac procedures|
|US5725496 *||24 Apr 1995||10 Mar 1998||Heartport, Inc.||Method for intraluminally inducing cardioplegic arrest and catheter for use therein|
|US5728151 *||5 Jun 1995||17 Mar 1998||Heartport, Inc.||Intercostal access devices for less-invasive cardiovascular surgery|
|US5735290 *||28 Jul 1994||7 Apr 1998||Heartport, Inc.||Methods and systems for performing thoracoscopic coronary bypass and other procedures|
|US5738652 *||17 Jan 1997||14 Apr 1998||Heartport, Inc.||Retrograde delivery catheter and method for inducing cardioplegic arrest|
|US5755687||1 Apr 1997||26 May 1998||Heartport, Inc.||Methods and devices for occluding a patient's ascending aorta|
|US5759170 *||13 Mar 1996||2 Jun 1998||Heartport, Inc.||Method for intraluminally inducing cardioplegic arrest and catheter for use therein|
|US5762624 *||20 Jun 1997||9 Jun 1998||Heartport, Inc.||Venous cannula|
|US5765568||1 Dec 1995||16 Jun 1998||Heartport, Inc.||Catheter system and method for venting the left ventricle|
|US5769812||16 Oct 1996||23 Jun 1998||Heartport, Inc.||System for cardiac procedures|
|US5772625 *||19 Nov 1996||30 Jun 1998||Heyer-Schulte Neurocare, Inc.||External drainage shunt|
|US5792094||28 Sep 1995||11 Aug 1998||Heartport, Inc.||Method of delivering cardioplegic fluid to a patient's heart|
|US5795325 *||11 Dec 1995||18 Aug 1998||Heartport, Inc.||Methods and apparatus for anchoring an occluding member|
|US5799661 *||7 Jun 1995||1 Sep 1998||Heartport, Inc.||Devices and methods for port-access multivessel coronary artery bypass surgery|
|US5800374 *||4 Aug 1992||1 Sep 1998||Beyersdorf; Friedhelm||Reperfusion device|
|US5800375||20 Dec 1995||1 Sep 1998||Heartport, Inc.||Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery|
|US5807318 *||12 Mar 1996||15 Sep 1998||Heartport, Inc.||Method of perfusing the coronary vasculature|
|US5810757||1 Dec 1995||22 Sep 1998||Heartport, Inc.||Catheter system and method for total isolation of the heart|
|US5814016 *||7 Feb 1997||29 Sep 1998||Heartport, Inc.||Endovascular system for arresting the heart|
|US5814097 *||14 May 1996||29 Sep 1998||Heartport, Inc.||Devices and methods for intracardiac procedures|
|US5820593 *||25 Apr 1996||13 Oct 1998||University Of Pittsburg Of The Commonwealth System Of Higher Education||Portable and modular cardiopulmonar bypass apparatus and associated aortic balloon catheter and associated method|
|US5830370 *||3 May 1995||3 Nov 1998||Maloney, Jr.; James V.||Mass and thermal transfer means for use in heart lung machines dialyzers and other applications|
|US5836311 *||20 Sep 1995||17 Nov 1998||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US5840060 *||7 Jun 1995||24 Nov 1998||Smith & Nephew, Inc.||Fluid management system|
|US5843024 *||17 May 1996||1 Dec 1998||Breonics, Inc.||Solution and process for resuscitation and preparation of ischemically damaged tissue|
|US5855210 *||6 Nov 1996||5 Jan 1999||Heartport, Inc.||Methods for performing heart surgery|
|US5863366 *||15 Nov 1996||26 Jan 1999||Heartport, Inc.||Method of manufacture of a cannula for a medical device|
|US5868702 *||17 Mar 1997||9 Feb 1999||Heartport, Inc.||System for cardiac procedures|
|US5868703 *||6 Dec 1996||9 Feb 1999||Endoscopic Technologies, Inc.||Multichannel catheter|
|US5879316 *||10 Apr 1997||9 Mar 1999||University Of Pittsburgh Of The Commonwealth System Of Higher Education||Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method|
|US5879321 *||22 Jan 1997||9 Mar 1999||The University Of Kentucky Research Foundation||Portocaval-right atrial shunt|
|US5879499 *||17 Jun 1996||9 Mar 1999||Heartport, Inc.||Method of manufacture of a multi-lumen catheter|
|US5882339 *||7 Jun 1995||16 Mar 1999||Smith & Nephew, Inc.||Fluid management system|
|US5885238||30 May 1995||23 Mar 1999||Heartport, Inc.||System for cardiac procedures|
|US5900142 *||30 Sep 1997||4 May 1999||Maloney, Jr.; James V.||Mass and thermal transfer means for use in heart lung machines, dialyzers, and other applications|
|US5906588 *||11 Aug 1997||25 May 1999||Cardeon Corporation||Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon and associated method|
|US5913842 *||11 Feb 1998||22 Jun 1999||Heartport, Inc.||Retrograde delivery catheter and method for inducing cardioplegic arrest|
|US5916191 *||30 Apr 1996||29 Jun 1999||Medtronic, Inc.||Pulsatile flow generation in heart-lung machines|
|US5916193 *||30 Nov 1996||29 Jun 1999||Heartport, Inc.||Endovascular cardiac venting catheter and method|
|US5927284 *||21 Aug 1997||27 Jul 1999||Medtronic, Inc||Method and apparatus for temporarily immobilizing a local area of tissue|
|US5935103||18 Jul 1997||10 Aug 1999||Heartport, Inc.||Blood vessel occlusion device|
|US5941894||18 Jul 1997||24 Aug 1999||Heartport, Inc.||Blood vessel occlusion device|
|US5957137 *||23 Dec 1997||28 Sep 1999||Cobe Cardiovascular Operating Co., Inc.||Controlled dilution controlled concentration cardioplegia solution administration|
|US5961481 *||12 Mar 1996||5 Oct 1999||Heartport, Inc.||Systems for coronary bypass procedures|
|US5965089 *||3 Oct 1997||12 Oct 1999||United States Surgical Corporation||Circulatory support system|
|US5971973 *||28 May 1998||26 Oct 1999||Heartport, Inc.||Method of occluding a patient's ascending aorta and returning oxygenated blood to the patient from a bypass system|
|US5980503 *||8 Apr 1996||9 Nov 1999||Guidant Corporation||Endoscopic cardioplegia infusion cannula and method of use|
|US5997505||18 Jul 1997||7 Dec 1999||Heartport, Inc.||Method of cannulating an ascending aorta using a blood vessel occlusion device|
|US6010531 *||31 Jan 1996||4 Jan 2000||Heartport, Inc.||Less-invasive devices and methods for cardiac valve surgery|
|US6015378 *||3 Oct 1996||18 Jan 2000||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area tissue|
|US6026814 *||6 Mar 1997||22 Feb 2000||Scimed Life Systems, Inc.||System and method for percutaneous coronary artery bypass|
|US6027476 *||19 Sep 1997||22 Feb 2000||Heartport, Inc.||Methods and systems for performing thoracoscopic coronary bypass and other procedures|
|US6029671 *||22 May 1996||29 Feb 2000||Heartport, Inc.||System and methods for performing endovascular procedures|
|US6035856 *||6 Mar 1997||14 Mar 2000||Scimed Life Systems||Percutaneous bypass with branching vessel|
|US6045531 *||22 Jul 1998||4 Apr 2000||Chase Medical Inc.||Catheter having a lumen occluding balloon and method of use thereof|
|US6053896 *||1 May 1998||25 Apr 2000||Cobe Cardiovascular Operating Co., Inc.||Left ventricle valve|
|US6056723||22 May 1998||2 May 2000||Heartport, Inc.||Methods and devices for occluding a patient's ascending aorta|
|US6068608 *||1 May 1997||30 May 2000||Chase Medical, Inc.||Method of using integral aortic arch infusion clamp|
|US6071295 *||20 Nov 1997||6 Jun 2000||Medivas Opcab, Inc.||Device to hold an anastomotic site of coronary artery motionless and bloodless for the bypass operation|
|US6090096 *||23 Apr 1997||18 Jul 2000||Heartport, Inc.||Antegrade cardioplegia catheter and method|
|US6092526 *||19 Jun 1997||25 Jul 2000||Scimed Life Systems, Inc.||Percutaneous chamber-to-artery bypass|
|US6106497 *||29 Jan 1998||22 Aug 2000||Medical Instrument Development Laboratories||System and method for preventing an air embolism in a surgical procedure|
|US6106776 *||11 Apr 1997||22 Aug 2000||University Of Pittsburgh||Membrane apparatus with enhanced mass transfer via active mixing|
|US6110139 *||21 Oct 1997||29 Aug 2000||Loubser; Paul Gerhard||Retrograde perfusion monitoring and control system|
|US6125852 *||23 Jul 1996||3 Oct 2000||Heartport, Inc.||Minimally-invasive devices and methods for treatment of congestive heart failure|
|US6132397 *||1 May 1997||17 Oct 2000||Chase Medical Inc.||Integral aortic arch infusion clamp catheter|
|US6139492 *||8 Apr 1999||31 Oct 2000||Heartport, Inc.||Device and method for isolating a surgical site|
|US6149583 *||6 May 1999||21 Nov 2000||Heartport, Inc.||Device and method for isolating a surgical site|
|US6155264 *||6 Mar 1997||5 Dec 2000||Scimed Life Systems, Inc.||Percutaneous bypass by tunneling through vessel wall|
|US6159178||23 Jan 1998||12 Dec 2000||Heartport, Inc.||Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested|
|US6165162 *||14 Sep 1998||26 Dec 2000||University Of Pittsburgh Of The Commonwealth System Of Higher Education||Method of using aortic balloon catheter|
|US6213126||19 Jun 1997||10 Apr 2001||Scimed Life Systems, Inc.||Percutaneous artery to artery bypass using heart tissue as a portion of a bypass conduit|
|US6217546||19 May 1997||17 Apr 2001||United States Surgical Corporation||Catheter system|
|US6217826||21 Sep 1998||17 Apr 2001||University Of Pittsburgh||Membrane apparatus with enhanced mass transfer, heat transfer and pumping capabilities via active mixing|
|US6224619||17 Sep 1996||1 May 2001||Heartport, Inc.||Blood vessel occlusion trocar having size and shape varying insertion body|
|US6231506||4 May 1999||15 May 2001||Cardiothoracic Systems, Inc.||Method and apparatus for creating a working opening through an incision|
|US6231585||9 Jun 1999||15 May 2001||Medivas, Llc||Device for stabilizing a treatment site and method of use|
|US6241699||22 Jul 1998||5 Jun 2001||Chase Medical, Inc.||Catheter system and method for posterior epicardial revascularization and intracardiac surgery on a beating heart|
|US6245007||28 Jan 1999||12 Jun 2001||Terumo Cardiovascular Systems Corporation||Blood pump|
|US6248086||23 Feb 1998||19 Jun 2001||Heartport, Inc.||Method for cannulating a patient's aortic arch and occluding the patient's ascending aortic arch|
|US6251093||13 Jul 1998||26 Jun 2001||Heartport, Inc.||Methods and apparatus for anchoring an occluding member|
|US6253769||7 Sep 1999||3 Jul 2001||Scimed Life Systems, Inc.||Method for percutaneous coronary artery bypass|
|US6283127||25 Sep 1998||4 Sep 2001||Wesley D. Sterman||Devices and methods for intracardiac procedures|
|US6283912||4 May 1999||4 Sep 2001||Cardiothoracic Systems, Inc.||Surgical retractor platform blade apparatus|
|US6290644||4 May 1999||18 Sep 2001||Cardiothoracic Systems, Inc.||Surgical instruments and procedures for stabilizing a localized portion of a beating heart|
|US6293920||7 Oct 1998||25 Sep 2001||Heartport, Inc.||Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery|
|US6311693||4 Oct 1999||6 Nov 2001||Wesley D. Sterman||Method and systems for performing thoracoscopic cardiac bypass and other procedures|
|US6315717||17 Apr 2000||13 Nov 2001||Cardiothoracic Systems, Inc.||Surgical instruments for stabilizing the beating heart during coronary artery bypass graft surgery|
|US6315751 *||15 Aug 1997||13 Nov 2001||Cleveland Clinic Foundation||Cardiopulmonary bypass system using vacuum assisted venous drainage|
|US6315768 *||8 Jun 1999||13 Nov 2001||Richard K. Wallace||Perfusion procedure and apparatus for preventing necrosis following failed balloon angioplasty|
|US6325813||18 Aug 1998||4 Dec 2001||Scimed Life Systems, Inc.||Method and apparatus for stabilizing vascular wall|
|US6328688||28 Jan 2000||11 Dec 2001||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US6331158||4 May 1999||18 Dec 2001||Cardiothoracic Systems, Inc.||Surgical retractor apparatus for operating on the heart through an incision|
|US6334843||28 Jan 2000||1 Jan 2002||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US6336898||28 Jan 2000||8 Jan 2002||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US6338710||16 Apr 1999||15 Jan 2002||Medivas, Llc||Device for stabilizing a treatment site and method of use|
|US6346077||27 Jan 1997||12 Feb 2002||Cardiothoracic Systems, Inc.||Surgical instrument for stabilizing the beating heart during coronary artery bypass graft surgery|
|US6348175||5 Oct 1999||19 Feb 2002||University Of Pittsburgh||Membrane apparatus with enhanced mass transfer via active mixing|
|US6350229||28 Jan 2000||26 Feb 2002||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US6364826||16 Jun 1999||2 Apr 2002||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US6371906||28 Jan 2000||16 Apr 2002||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US6390098||23 Dec 1999||21 May 2002||Scimed Life Systems, Inc.||Percutaneous bypass with branching vessel|
|US6394948||28 Jan 2000||28 May 2002||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US6394951||13 Mar 2000||28 May 2002||Cardiothoracic Systems, Inc.||Surgical instruments and procedures for stabilizing the beating heart during coronary artery bypass graft surgery|
|US6398752||5 Jun 1998||4 Jun 2002||William P. Sweezer, Jr.||Method of occluding a patient's ascending aorta and delivery cardioplegic fluid|
|US6401721||8 Nov 1999||11 Jun 2002||Cardiothoracic Systems, Inc.||Endoscopic bypass grafting method utilizing an inguinal approach|
|US6406424||16 Sep 1999||18 Jun 2002||Williamson, Iv Warren P.||Tissue stabilizer having an articulating lift element|
|US6423031||1 Nov 1999||23 Jul 2002||Brian S. Donlon||Methods and devices for occluding a patient's ascending aorta|
|US6435189||20 Aug 1999||20 Aug 2002||Salient Interventional Systems, Inc.||Methods and systems for treating ischemia|
|US6436087 *||20 Aug 1999||20 Aug 2002||Salient Interventional Systems, Inc.||Methods and systems for treating ischemia|
|US6443158||1 Jun 1998||3 Sep 2002||Scimed Life Systems, Inc.||Percutaneous coronary artery bypass through a venous vessel|
|US6443922 *||23 Sep 1999||3 Sep 2002||Heartport, Inc.||Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart|
|US6451004 *||19 Jul 1999||17 Sep 2002||William S Peters||Method for intraluminally inducing cardioplegic arrest and catheter for use therein|
|US6464629||15 Sep 1999||15 Oct 2002||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US6464630||28 Jan 2000||15 Oct 2002||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US6481439||20 Aug 1999||19 Nov 2002||Salient Interventional Systems, Inc.||Methods and systems for treating ischemia|
|US6482151||3 Oct 2000||19 Nov 2002||Heartport, Inc.||Method of performing a procedure on a coronary artery|
|US6482171||13 Jan 1997||19 Nov 2002||Heartport, Inc.||Multi-lumen catheter|
|US6494211||19 Jan 2000||17 Dec 2002||Hearport, Inc.||Device and methods for port-access multivessel coronary artery bypass surgery|
|US6494897||4 Sep 2001||17 Dec 2002||Heartport, Inc.||Methods and systems for performing thoracoscopic cardiac bypass and other procedures|
|US6511416||3 Aug 1999||28 Jan 2003||Cardiothoracic Systems, Inc.||Tissue stabilizer and methods of use|
|US6533770 *||21 Jan 1998||18 Mar 2003||Heartport, Inc.||Cannula and method of manufacture and use|
|US6558318||1 Nov 1999||6 May 2003||Heartport, Inc.||Endoscopic retraction method|
|US6565582||19 Jun 2002||20 May 2003||Hearport, Inc.||Devices and methods for performing a vascular anastomosis|
|US6575168||12 Jan 2001||10 Jun 2003||Scimed Life Systems, Inc.||System and method for percutaneous coronary artery bypass|
|US6579259 *||25 Jun 1999||17 Jun 2003||Heartport, Inc.||Endovacular cardiac venting catheter and method|
|US6589206||10 Oct 2000||8 Jul 2003||Heartport, Inc.||Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested|
|US6599313 *||30 Dec 1999||29 Jul 2003||Cardiothoracic Systems, Inc.||Extravascular bypass grafting method utilizing an intravascular approach|
|US6613069||19 Oct 2001||2 Sep 2003||Heartport, Inc.||Tunneling instrument for port access multivessel coronary artery bypass surgery|
|US6622367||4 Nov 1999||23 Sep 2003||Salient Interventional Systems, Inc.||Intravascular device and method of manufacture and use|
|US6626830||1 Dec 1999||30 Sep 2003||Cardiothoracic Systems, Inc.||Methods and devices for improved tissue stabilization|
|US6632189||3 Sep 1999||14 Oct 2003||Edwards Lifesciences Corporation||Support device for surgical systems|
|US6651671||12 Oct 1999||25 Nov 2003||Heartport, Inc.||Lens-invasive devices and methods for cardiac valve surgery|
|US6651672||28 Aug 2001||25 Nov 2003||Heartport, Inc.||Devices for less-invasive intracardiac interventions|
|US6652454||10 Jan 2001||25 Nov 2003||Lawrence W. Hu||Method and apparatus for creating a working opening through an incision|
|US6656113||25 May 2001||2 Dec 2003||Cardiothoracic System, Inc.||Surgical instruments and procedures for stabilizing a localized portion of a beating heart|
|US6673013||9 Apr 2001||6 Jan 2004||Cardiothoracic Systems, Inc.||Surgical instruments and procedures for stabilizing the beating heart during coronary artery bypass graft surgery|
|US6676597||12 Jun 2001||13 Jan 2004||Medtronic, Inc.||Method and device for organ positioning|
|US6685632||4 May 2000||3 Feb 2004||Cardiothoracic Systems, Inc.||Surgical instruments for accessing and stabilizing a localized portion of a beating heart|
|US6689315||5 Apr 2002||10 Feb 2004||Cardiovention, Inc.||Integrated blood handling system having improved pump|
|US6699257||20 Jun 2002||2 Mar 2004||Heartport, Inc||Devices and methods for performing a vascular anastomosis|
|US6701930||6 Nov 2001||9 Mar 2004||Cardiothoracic Systems, Inc.||Surgical instruments and procedures for stabilizing the beating heart during coronary artery bypass graft surgery|
|US6705988||28 Dec 2001||16 Mar 2004||Origin Medsystems, Inc.||Device to permit offpump beating heart coronary bypass surgery|
|US6716189||8 Jun 1999||6 Apr 2004||United States Surgical Corporation||Circulatory support system|
|US6723284||6 Nov 2000||20 Apr 2004||University Of Pittsburgh||Membrane apparatus with enhanced mass transfer, heat transfer and pumping capabilities via active mixing|
|US6730267||9 Feb 2001||4 May 2004||Cardiovention, Inc.||Integrated blood handling system having active gas removal system and methods of use|
|US6736790||11 Jul 2001||18 May 2004||Denise R. Barbut||Method and system for selective or isolated integrate cerebral perfusion and cooling|
|US6740028||13 Mar 2002||25 May 2004||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US6743169||10 Oct 2001||1 Jun 2004||Cardiothoracic Systems, Inc.|
|US6743170||18 Sep 2001||1 Jun 2004||Cardiothoracic Systems, Inc.||Device to permit offpump beating heart coronary bypass surgery|
|US6755780||30 Apr 2002||29 Jun 2004||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US6758808||24 Jan 2001||6 Jul 2004||Cardiothoracic System, Inc.||Surgical instruments for stabilizing a localized portion of a beating heart|
|US6773670||5 Feb 2002||10 Aug 2004||Cardiovention, Inc. C/O The Brenner Group, Inc.||Blood filter having a sensor for active gas removal and methods of use|
|US6802319||24 Mar 2000||12 Oct 2004||John H. Stevens||Minimally-invasive devices and methods for treatment of congestive heart failure|
|US6821247||27 Sep 2002||23 Nov 2004||Heartport, Inc.||Device and method for isolating a surgical site|
|US6821265||10 Apr 1997||23 Nov 2004||Endoscopic Technologies, Inc.||Multichannel catheter|
|US6852075||15 Nov 1999||8 Feb 2005||Cardiothoracic Systems, Inc.||Surgical devices for imposing a negative pressure to stabilize cardiac tissue during surgery|
|US6866650 *||2 Feb 2001||15 Mar 2005||Heartport, Inc.||System for cardiac procedures|
|US6893391||14 Dec 2001||17 May 2005||Cardiothoracic Systems, Inc.||Surgical devices for imposing a negative pressure to stabilize cardiac tissue during surgery|
|US6899704||10 Jul 2001||31 May 2005||Heartport, Inc.||Devices and methods for intracardiac procedures|
|US6902545||1 Sep 1998||7 Jun 2005||Endoscopic Technologies, Inc.||Multichannel catheter|
|US6902556 *||5 Jun 2002||7 Jun 2005||Heartport, Inc.||Methods and devices for occluding the ascending aorta and maintaining circulation oxygenated blood in the patient when the patient's heart is arrested|
|US6905481 *||2 Dec 2002||14 Jun 2005||Orqis Medical Corporation||Percutaneous catheter assembly|
|US6905514||12 Nov 2003||14 Jun 2005||Kinamed, Inc.||Custom replacement device for resurfacing a femur and method of making the same|
|US6913600||25 Sep 1998||5 Jul 2005||Heartport, Inc.||Endovascular system for arresting the heart|
|US6913601||22 May 2001||5 Jul 2005||Heartport, Inc.||Method for delivering a fluid to the coronary ostia|
|US6929634 *||1 Apr 2002||16 Aug 2005||Gore Enterprise Holdings, Inc.||Apparatus and methods for treating stroke and controlling cerebral flow characteristics|
|US6932792||17 Jul 2000||23 Aug 2005||Frederick G. St. Goar||Antegrade cardioplegia catheter and method|
|US6946099 *||31 Mar 2003||20 Sep 2005||Venkataramana Vijay||Methods of using condensed perfusion circuit for cardiopulmonary bypass and cardioplegia|
|US6960322||8 Jul 2003||1 Nov 2005||Cardiovention, Inc.||Integrated blood handling system having active gas removal system and methods of use|
|US6969349||31 Mar 2003||29 Nov 2005||Origin Medsystem, Inc.||Device to permit offpump beating heart coronary bypass surgery|
|US6986778||22 Jan 2001||17 Jan 2006||Medtronic Vascular, Inc.||Exchange method for emboli containment|
|US7004175||13 May 2003||28 Feb 2006||Scimed Life Systems, Inc.||System and method for percutaneous coronary artery bypass|
|US7017581||19 Oct 2001||28 Mar 2006||Boyd Stephen W||Devices and methods for port-access multivessel coronary artery bypass surgery|
|US7022099||17 Mar 2003||4 Apr 2006||Cardiovention, Inc.||Extracorporeal blood handling system with automatic flow control and methods of use|
|US7025722||30 Apr 2004||11 Apr 2006||Heartport, Inc.||Device and method for isolating a surgical site|
|US7028692||19 Sep 2001||18 Apr 2006||Heartport, Inc.||Methods and systems for performing thoracoscopic coronary bypass and other procedures|
|US7033383||13 Apr 2004||25 Apr 2006||Cardiothoracic Systems, Inc.||Endoscopic bypass grafting method utilizing an inguinal approach|
|US7048683||30 Apr 2002||23 May 2006||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US7056287||14 Mar 2002||6 Jun 2006||Cardiothoracic Systems, Inc.|
|US7122151||19 Apr 2004||17 Oct 2006||University Of Pittsburgh||Membrane apparatus with enhanced mass transfer, heat transfer and pumping capabilities via active mixing|
|US7131447||26 Apr 2004||7 Nov 2006||Heartport, Inc.||Methods and systems for performing thoracoscopic coronary bypass and other procedures|
|US7144365||5 Dec 2003||5 Dec 2006||Orqis Medical Corporation||Implantable heart assist system and method of applying same|
|US7179224||30 Dec 2003||20 Feb 2007||Cardiothoracic Systems, Inc.||Organ manipulator and positioner and methods of using the same|
|US7189201||30 Apr 2002||13 Mar 2007||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US7189352||22 Dec 2003||13 Mar 2007||Medtronic, Inc.||Extracorporeal blood circuit priming system and method|
|US7195591||23 Feb 2005||27 Mar 2007||Origin Medsystems, Inc.||Device to permit offpump beating heart coronary bypass surgery|
|US7198751||22 Dec 2003||3 Apr 2007||Medtronic, Inc.||Disposable, integrated, extracorporeal blood circuit|
|US7201716||18 Feb 2004||10 Apr 2007||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US7201870||22 Dec 2003||10 Apr 2007||Medtronic, Inc.||Active air removal system operating modes of an extracorporeal blood circuit|
|US7204958||22 Dec 2003||17 Apr 2007||Medtronic, Inc.||Extracorporeal blood circuit air removal system and method|
|US7213601||17 Sep 2003||8 May 2007||Heartport, Inc||Minimally-invasive devices and methods for treatment of congestive heart failure|
|US7219671||7 Jan 2003||22 May 2007||Cardiothoracic Systems, Inc.||Method for coronary artery bypass|
|US7220228||6 Jul 2001||22 May 2007||Cardiothoracic System, Inc.||Surgical retractor blade and system|
|US7238155||23 Sep 2003||3 Jul 2007||Cardiothoracic Systems, Inc.||Method and apparatus for creating a working opening through an incision|
|US7264606||5 Apr 2004||4 Sep 2007||United States Surgical Corporation||Circulatory support system|
|US7326173||19 Nov 2003||5 Feb 2008||Medtronic, Inc.||Device for organ positioning|
|US7326177||30 Apr 2002||5 Feb 2008||Cardiothoracic Systems, Inc.||Tissue stabilizer having an articulating lift element|
|US7326195||18 Nov 2003||5 Feb 2008||Boston Scientific Scimed, Inc.||Targeted cooling of tissue within a body|
|US7331921||28 Jun 2004||19 Feb 2008||Orqis Medical Corporation||Implantable heart assist system and method of applying same|
|US7335158||8 Aug 2002||26 Feb 2008||Cardiothoracic Systems, Inc.||Surgical devices for imposing a negative pressure to stabilize the cardiac tissue during surgery|
|US7335334||22 Dec 2003||26 Feb 2008||Medtronic, Inc.||Active air removal from an extracorporeal blood circuit|
|US7338434||19 Aug 2003||4 Mar 2008||Medtronic, Inc.||Method and system for organ positioning and stabilization|
|US7371223||2 Oct 2002||13 May 2008||Boston Scientific Scimed, Inc.||Electroactive polymer actuated heart-lung bypass pumps|
|US7377895||31 Oct 2003||27 May 2008||Origin Medsystems, Inc.||Device to permit offpump beating heart coronary bypass surgery|
|US7399272||24 Mar 2004||15 Jul 2008||Medtronic, Inc.||Methods and apparatus providing suction-assisted tissue engagement|
|US7404792||24 Dec 2003||29 Jul 2008||Origin Medsystems, Inc.||Device to permit offpump beating heart coronary bypass surgery|
|US7410459 *||18 Jul 2001||12 Aug 2008||Dai-Yuan Wang||Cardiac support device and method|
|US7438680||3 Sep 2003||21 Oct 2008||Medtronic, Inc.||Method and device for organ positioning|
|US7445592||10 Jun 2004||4 Nov 2008||Orqis Medical Corporation||Cannulae having reduced flow resistance|
|US7445594||2 Oct 2000||4 Nov 2008||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US7455812 *||16 Jun 2004||25 Nov 2008||Rheoxtech, Llc||Method and apparatus for controlled reoxygenation|
|US7458929||3 May 2005||2 Dec 2008||Orqis Medical Corporation||Implantable heart assist system and method of applying same|
|US7458952||14 Nov 2005||2 Dec 2008||Venkataramana Vijay||Integrated cardiopulmonary bypass system for open and closed bypass circuits|
|US7476196||8 Jun 2004||13 Jan 2009||Maquet Cardiovascular, Llc||Device to permit offpump beating heart coronary bypass surgery|
|US7476199||24 Mar 2003||13 Jan 2009||Maquet Cardiovascular, Llc.||Device to permit offpump beating heart coronary bypass surgery|
|US7479104||8 Jul 2003||20 Jan 2009||Maquet Cardiovascular, Llc||Organ manipulator apparatus|
|US7485090||21 Sep 2004||3 Feb 2009||Maquet Cardiovascular Llc||Surgical devices for imposing a negative pressure to stabilize cardiac tissue during surgery|
|US7485109||17 Feb 2006||3 Feb 2009||Boston Scientific Scimed, Inc.||Targeted cooling of tissue within a body|
|US7494460||30 Sep 2003||24 Feb 2009||Medtronic, Inc.||Methods and apparatus providing suction-assisted tissue engagement through a minimally invasive incision|
|US7497824||16 Sep 2004||3 Mar 2009||Maquet Cardiovasculer, Llc||Surgical devices for imposing a negative pressure to stabilize cardiac tissue during surgery|
|US7503891||15 Oct 2002||17 Mar 2009||Maquet Cardiovascular, Llc||Tissue stabilizer and methods of use|
|US7513863||28 Jun 2004||7 Apr 2009||Orqis Medical Corporation||Implantable heart assist system and method of applying same|
|US7527608 *||30 Jul 2004||5 May 2009||Lma North America, Inc.||Medication infusion and aspiration system and method|
|US7541000||26 Sep 2005||2 Jun 2009||Cardiovention, Inc.||Micro-processor controlled active gas removal apparatus|
|US7585277||1 Feb 2006||8 Sep 2009||Maquet Cardiovascular Llc|
|US7588531||3 May 2006||15 Sep 2009||Orqis Medical Corporation||Implantable heart assist system and method of applying same|
|US7591778||3 May 2006||22 Sep 2009||Orqis Medical Corporation||Implantable heart assist system and method of applying same|
|US7597697||11 Jul 2001||6 Oct 2009||Boston Scientific Scimed, Inc.||Bypass grafting method|
|US7611455||13 Oct 2005||3 Nov 2009||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US7614997||3 May 2006||10 Nov 2009||Orqis Medical Corporation||Implantable heart assist system and method of applying same|
|US7686781||25 Oct 2002||30 Mar 2010||Emory University||Catheter for modified perfusion|
|US7704455||5 Feb 2007||27 Apr 2010||Medtronic, Inc.||Active air removal system operating modes of an extracorporeal blood circuit|
|US7708942 *||12 Feb 2008||4 May 2010||Rheoxtech, Llc||Method and apparatus for controlled reoxygenation|
|US7736307||12 Dec 2003||15 Jun 2010||Maquet Cardiovascular Llc||Surgical instruments for accessing and stabilizing a localized portion of a beating heart|
|US7740800||5 Feb 2007||22 Jun 2010||Medtronic, Inc.||Extracorporeal blood circuit air removal system and method|
|US7753946||9 Feb 2007||13 Jul 2010||Boston Scientific Scimed, Inc.||Bypass grafting system and apparatus|
|US7794387||25 Apr 2007||14 Sep 2010||Medtronic, Inc.||Methods and devices for stabilizing tissue|
|US7829018||13 Jun 2007||9 Nov 2010||Medtronic, Inc.||Active air removal from an extracorporeal blood circuit|
|US7833268 *||28 Apr 2006||16 Nov 2010||Delgado Iii Reynolds M||Method and apparatus for implanting an aortic valve prosthesis|
|US7867266 *||13 Nov 2006||11 Jan 2011||Zoll Circulation, Inc.||Temperature management system with assist mode for use with heart-lung machine|
|US7879022||1 Apr 2005||1 Feb 2011||Medrad, Inc.||Rapid exchange fluid jet thrombectomy device and method|
|US7914514 *||16 Jun 2005||29 Mar 2011||Reynaldo Calderon||Computerized system for monitored retrograde perfusion of tumor sites|
|US7931590||29 Oct 2002||26 Apr 2011||Maquet Cardiovascular Llc||Tissue stabilizer and methods of using the same|
|US7947030 *||30 Dec 2004||24 May 2011||Reynaldo Calderon||Retrograde perfusion of tumor sites|
|US7967833||15 Sep 2004||28 Jun 2011||Edwards Lifesciences Llc||Devices and methods for intracardiac procedures|
|US7981072 *||31 Dec 2009||19 Jul 2011||Olympus Corporation||Method and apparatus for supplying predetermined gas into body cavities of a patient|
|US7993260||10 Nov 2009||9 Aug 2011||Thoratec Corporation||Implantable heart assist system and method of applying same|
|US7996974||16 Jul 2008||16 Aug 2011||Medrad, Inc.||Method of manufacturing a miniature flexible thrombectomy catheter|
|US8012117||6 Feb 2007||6 Sep 2011||Medrad, Inc.||Miniature flexible thrombectomy catheter|
|US8025620||3 Aug 2010||27 Sep 2011||Medtronic, Inc.||Methods and devices for stabilizing tissue|
|US8083664||25 May 2005||27 Dec 2011||Maquet Cardiovascular Llc||Surgical stabilizers and methods for use in reduced-access surgical sites|
|US8142383 *||29 Oct 2004||27 Mar 2012||Gambro Ab||Fluid distribution module and extracorporeal blood circuit including such a module|
|US8162817||10 Dec 2008||24 Apr 2012||Maquet Cardiovascular Llc||Device to permit offpump beating heart coronary bypass surgery|
|US8162877||17 Jul 2008||24 Apr 2012||Medrad, Inc.||Enhanced cross stream mechanical thrombectomy catheter|
|US8162878||5 Dec 2005||24 Apr 2012||Medrad, Inc.||Exhaust-pressure-operated balloon catheter system|
|US8178041||29 Mar 2010||15 May 2012||Rheoxtech, Llc||Method and apparatus for controlled reoxygenation|
|US8277476||14 Oct 2003||2 Oct 2012||Maguet Cardiovascular LLC||Surgical instruments and procedures for stabilizing the beating heart during coronary artery bypass graft|
|US8303538||17 Dec 2008||6 Nov 2012||Medrad, Inc.||Rheolytic thrombectomy catheter with self-inflating distal balloon|
|US8303569 *||21 Nov 2006||6 Nov 2012||Medtronic Vascular, Inc.||Composite laminated catheter with flexible segment and method of making same|
|US8308712 *||19 Apr 2006||13 Nov 2012||Medronic Vascular, Inc.||Composite laminated catheter with flexible segment and method of making same|
|US8317695||16 Dec 2008||27 Nov 2012||Maquet Cardiovascular Llc||Device to permit offpump beating heart coronary bypass surgery|
|US8328877||19 Mar 2002||11 Dec 2012||Boston Scientific Scimed, Inc.||Stent retention element and related methods|
|US8353907||18 Dec 2008||15 Jan 2013||Atricure, Inc.||Ablation device with internally cooled electrodes|
|US8382654||23 Mar 2011||26 Feb 2013||Maquet Cardiovascular Llc||Surgical devices for imposing a negative pressure to stabilize the cardiac tissue during surgery|
|US8403858 *||25 Jul 2007||26 Mar 2013||Perceptive Navigation Llc||Image guided catheters and methods of use|
|US8419741||16 Apr 2013||Kinamed, Inc.||Marking template for installing a custom replacement device for resurfacing a femur and associated installation method|
|US8439878||18 Dec 2008||14 May 2013||Medrad, Inc.||Rheolytic thrombectomy catheter with self-inflating proximal balloon with drug infusion capabilities|
|US8449449||8 Dec 2008||28 May 2013||Medtronic, Inc.||Methods and apparatus providing suction-assisted tissue engagement through a minimally invasive incision|
|US8562585||17 Jul 2009||22 Oct 2013||Rheoxtech, Llc||Method and apparatus for mitigating acute reoxygenation injury during percutaneous coronary intervention|
|US8597238||23 Apr 2012||3 Dec 2013||Medrad, Inc.||Enhanced cross stream mechanical thrombectomy catheter|
|US8641598||18 Dec 2008||4 Feb 2014||Maquet Cardiovascular Llc||Organ manipulator apparatus|
|US8647294||20 Mar 2009||11 Feb 2014||Medrad, Inc.||Direct stream hydrodynamic catheter system|
|US8709343||14 May 2012||29 Apr 2014||Rheoxtech, Llc||Method and apparatus for controlled reoxygenation|
|US8734320||28 Mar 2013||27 May 2014||Medtronic, Inc.||Methods and apparatus providing suction-assisted tissue engagement through a minimally invasive incision|
|US8753266||7 Feb 2007||17 Jun 2014||Maquet Cardiovascular Llc||Device to permit offpump beating heart coronary bypass surgery|
|US8888737||20 Oct 2009||18 Nov 2014||Rheoxtech, Llc||Method and apparatus for cardiac tissue monitoring and catheter-based perfusion for mitigating acute reoxygenation injury|
|US8900060||29 Apr 2010||2 Dec 2014||Ecp Entwicklungsgesellschaft Mbh||Shaft arrangement having a shaft which extends within a fluid-filled casing|
|US8900115||1 Jul 2011||2 Dec 2014||Thoratec Corporation||Implantable heart assist system and method of applying same|
|US8915878||14 Jan 2013||23 Dec 2014||Atricure, Inc.||Ablation device with internally cooled electrodes|
|US8926492||30 Apr 2014||6 Jan 2015||Ecp Entwicklungsgesellschaft Mbh||Housing for a functional element|
|US8932141||22 Oct 2010||13 Jan 2015||Ecp Entwicklungsgesellschaft Mbh||Flexible shaft arrangement|
|US8936601 *||12 Mar 2014||20 Jan 2015||Kinamed, Inc.||Marking template for installing a custom replacement device for resurfacing a femur and associated installation method|
|US8936602 *||12 Mar 2014||20 Jan 2015||Kinamed, Inc.||Marking template for installing a custom replacement device for resurfacing a femur and associated installation method|
|US8944748||29 Apr 2010||3 Feb 2015||Ecp Entwicklungsgesellschaft Mbh||Fluid pump changeable in diameter, in particular for medical application|
|US8974418||22 Jan 2008||10 Mar 2015||Boston Scientific Limited||Forwardly directed fluid jet crossing catheter|
|US8979493||18 Mar 2010||17 Mar 2015||ECP Entwicklungsgesellscaft mbH||Fluid pump|
|US8998792||12 May 2014||7 Apr 2015||Ecp Entwicklungsgesellschaft Mbh||Fluid pump with a rotor|
|US8998843||26 Nov 2013||7 Apr 2015||Boston Scientific Limited||Enhanced cross stream mechanical thrombectomy catheter|
|US8998892||26 Apr 2010||7 Apr 2015||Atricure, Inc.||Ablation device with cooled electrodes and methods of use|
|US9022998||26 Feb 2010||5 May 2015||Maquet Cardiovascular Llc||Blower instrument, apparatus and methods of using|
|US9028216||22 Sep 2010||12 May 2015||Ecp Entwicklungsgesellschaft Mbh||Rotor for an axial flow pump for conveying a fluid|
|US9067006||25 Jun 2010||30 Jun 2015||Ecp Entwicklungsgesellschaft Mbh||Compressible and expandable blade for a fluid pump|
|US9084856||27 Sep 2013||21 Jul 2015||Rheoxtech, Llc||Method and apparatus for mitigating acute reoxygenation injury during percutaneous coronary intervention|
|US9089634||22 Sep 2010||28 Jul 2015||Ecp Entwicklungsgesellschaft Mbh||Fluid pump having at least one impeller blade and a support device|
|US9089670||3 Feb 2010||28 Jul 2015||Ecp Entwicklungsgesellschaft Mbh||Catheter device having a catheter and an actuation device|
|US20010023334 *||22 May 2001||20 Sep 2001||Heartport, Inc.||Method for delivering a fluid to the coronary ostia|
|US20020004628 *||6 Jul 2001||10 Jan 2002||Hu Lawrence W.||Surgical retractor platform blade apparatus|
|US20020016565 *||18 May 1999||7 Feb 2002||Gholam-Reza Zadno-Azizi||Catheter system for emboli containment|
|US20020056460 *||19 Oct 2001||16 May 2002||Boyd Stephen W.||Devices and methods for port-access multivessel coronary artery bypass surgery|
|US20020065451 *||28 Dec 2001||30 May 2002||Spence Paul A.||Device to permit offpump beating heart coronary bypass surgery|
|US20020065507 *||22 Jan 2001||30 May 2002||Gholam-Reza Zadno-Azizi||Exchange method for emboli containment|
|US20040068220 *||2 Oct 2002||8 Apr 2004||Couvillon, Lucien Alfred||Electroactive polymer actuated heart-lung bypass pumps|
|US20040082830 *||19 Nov 2003||29 Apr 2004||Guenst Gary W.||Device for organ positioning|
|US20040087834 *||29 Oct 2003||6 May 2004||Benetti Federico J.|
|US20040092798 *||31 Oct 2003||13 May 2004||Spence Paul A.||Device to permit offpump beating heart coronary bypass surgery|
|US20040098133 *||12 Nov 2003||20 May 2004||Roger Carignan||Custom replacement device for resurfacing a femur and method of making the same|
|US20040111079 *||3 Dec 2003||10 Jun 2004||Richard Hayes||Targeted sanguinous drug solution delivery to a targeted organ|
|US20040116768 *||5 Dec 2003||17 Jun 2004||Bolling Steven F.||Implantable heart assist system and method of applying same|
|US20040117032 *||21 Nov 2003||17 Jun 2004||Roth Alex T.||Devices for less-invasive intracardiac interventions|
|US20040138522 *||30 Sep 2003||15 Jul 2004||Haarstad Philip J.|
|US20040138533 *||24 Dec 2003||15 Jul 2004||Spence Paul A.||Device to permit offpump beating heart coronary bypass surgery|
|US20040138608 *||23 Dec 2003||15 Jul 2004||Barbut Denise R.||Method and system for selective or isolated integrate cerebral perfusion and cooling|
|US20040167549 *||18 Feb 2004||26 Aug 2004||Eric Boone||Method and apparatus for temporarily immobilizing a local area of tissue|
|US20040184953 *||17 Mar 2003||23 Sep 2004||Litzie A. Kenneth||Extracorporeal blood handling system with automatic flow control and methods of use|
|US20040191116 *||5 Apr 2004||30 Sep 2004||Robert Jarvik||Circulatory support system|
|US20040193091 *||31 Mar 2003||30 Sep 2004||Venkataramana Vijay||Methods of using condensed perfusion circuit for cardiopulmonary bypass and cardioplegia|
|US20040194791 *||26 Apr 2004||7 Oct 2004||Sterman Wesley D.||Methods and systems for performing thoracoscopic coronary bypass and other procedures|
|US20040195178 *||22 Dec 2003||7 Oct 2004||Carpenter Walter L.||Extracorporeal blood circuit priming system and method|
|US20040197223 *||22 Dec 2003||7 Oct 2004||Olsen Robert W.||Active air removal system operating modes of an extracorporeal blood circuit|
|US20040217054 *||22 Dec 2003||4 Nov 2004||Olsen Robert W.||Extracorporeal blood circuit air removal system and method|
|US20040219061 *||19 Apr 2004||4 Nov 2004||University Of Pittsburgh|
|US20040220509 *||22 Dec 2003||4 Nov 2004||Olsen Robert W.||Active air removal from an extracorporeal blood circuit|
|US20040225195 *||8 Jun 2004||11 Nov 2004||Spence Paul A.||Device to permit offpump beating heart coronary bypass surgery|
|US20040228760 *||21 Jun 2004||18 Nov 2004||Cardiovention, Inc.||Methods of use of a blood filter having a sensor for active gas removal|
|US20040230099 *||14 Oct 2003||18 Nov 2004||Taylor Charles S.|
|US20040236172 *||28 Jun 2004||25 Nov 2004||Bolling Steven F.||Implantable heart assist system and method of applying same|
|US20040236173 *||28 Jun 2004||25 Nov 2004||Anthony Viole||Implantable heart assist system and method of applying same|
|US20040254425 *||30 Apr 2004||16 Dec 2004||Vierra Mark A.||Device and method for isolating a surgical site|
|US20050010197 *||8 Jul 2003||13 Jan 2005||Liming Lau||Organ manipulator apparatus|
|US20050033111 *||16 Sep 2004||10 Feb 2005||Taylor Charles S.||Surgical devices for imposing a negative pressure to stabilize cardiac tissue during surgery|
|US20050038316 *||21 Sep 2004||17 Feb 2005||Taylor Charles S.||Surgical devices for imposing a negative pressure to stabilize cardiac tissue during surgery|
|US20050063860 *||22 Dec 2003||24 Mar 2005||Carpenter Walter L.||Disposable, integrated, extracorporeal blood circuit|
|US20050084416 *||16 Jun 2004||21 Apr 2005||Thomas Neil J.||Method and apparatus for controlled reoxygenation|
|US20050085683 *||15 Oct 2003||21 Apr 2005||Bolling Steven F.||Implantable heart assist system and method of applying same|
|US20050085762 *||18 Nov 2004||21 Apr 2005||Venkataramana Vijay||Perfusion circuit for cardiopulmonary bypass with air removal system|
|US20050107741 *||18 Nov 2003||19 May 2005||Martin Willard||Targeted cooling of tissue within a body|
|US20050119664 *||7 Jan 2005||2 Jun 2005||Kinamed, Inc.|
|US20050124973 *||20 Jan 2005||9 Jun 2005||Gerald Dorros||Apparatus and methods for treating stroke and controlling cerebral flow characteristics|
|US20050148822 *||30 Dec 2003||7 Jul 2005||Willis Geoffrey H.||Organ manipulator and positioner and methods of using the same|
|US20050148824 *||30 Dec 2003||7 Jul 2005||Morejohn Dwight P.||Transabdominal surgery system|
|US20050148825 *||23 Feb 2005||7 Jul 2005||Spence Paul A.||Device to permit offpump beating heart coronary bypass surgery|
|US20050148997 *||14 Feb 2005||7 Jul 2005||Valley Kirsten L.||Methods and apparatus for anchoring an occluding member|
|US20050245866 *||23 Jun 2005||3 Nov 2005||Medtronic Vascular, Inc.||Exchange method for emboli containment|
|US20050256363 *||3 May 2005||17 Nov 2005||Bolling Steven F||Implantable heart assist system and method of applying same|
|US20050267323 *||6 Jun 2005||1 Dec 2005||Gerald Dorros||Apparatus and methods for treating stroke and controlling cerebral flow characteristics|
|US20050277803 *||10 Jun 2004||15 Dec 2005||Robert Pecor||Cannulae having reduced flow resistance|
|US20050277870 *||10 Jun 2004||15 Dec 2005||Robert Pecor||Cannula having reduced flow resistance|
|US20050277979 *||15 Aug 2005||15 Dec 2005||Gerald Dorros||Apparatus and methods for treating stroke and controlling cerebral flow characteristics|
|US20060025840 *||2 Aug 2004||2 Feb 2006||Martin Willard||Cooling tissue inside the body|
|US20060029515 *||26 Sep 2005||9 Feb 2006||Cardiovention, Inc.||Integrated blood handling system having active gas removal system and method of use|
|US20060036128 *||13 Oct 2005||16 Feb 2006||Medtronic, Inc.||Method and apparatus for temporarily immobilizing a local area of tissue|
|US20060052802 *||15 Sep 2004||9 Mar 2006||Sterman Wesley D||Devices and methods for intracardiac procedures|
|US20060052803 *||1 Nov 2005||9 Mar 2006||Maginot Thomas J||Graft implant method|
|US20060142826 *||17 Feb 2006||29 Jun 2006||Scimed Life Systems, Inc., A Delaware Corporation||Targeted cooling of tissue within a body|
|US20060142827 *||17 Feb 2006||29 Jun 2006||Scimed Life Systems, Inc.||Targeted cooling of tissue within a body|
|US20060149219 *||30 Dec 2004||6 Jul 2006||Reynaldo Calderon||Retrograde perfusion of tumor sites|
|US20060149393 *||16 Jun 2005||6 Jul 2006||Reynaldo Calderon||Computerized system for monitored retrograde perfusion of tumor sites|
|US20060155237 *||14 Nov 2005||13 Jul 2006||Venkataramana Vijay||Integrated cardiopulmonary bypass system for open and closed bypass circuits|
|US20060161173 *||13 Mar 2006||20 Jul 2006||Maginot Thomas J||Endoscopic bypass grafting method utilizing an inguinal approach|
|US20060184199 *||14 Feb 2005||17 Aug 2006||O'leary Shawn||Apparatus and methods for reducing bleeding from a cannulation site|
|US20060200074 *||3 May 2006||7 Sep 2006||Gholam-Reza Zadno-Azizi||Method and apparatus for emboli containment|
|US20060200075 *||3 May 2006||7 Sep 2006||Gholam-Reza Zadno-Azizi||Method and apparatus for emboli containment|
|US20060211947 *||7 Mar 2006||21 Sep 2006||Nikolai Krivitski||System and method for determining cardiac output|
|US20060224110 *||17 Mar 2005||5 Oct 2006||Scott Michael J||Methods for minimally invasive vascular access|
|US20060225747 *||23 May 2006||12 Oct 2006||Maginot Thomas J||Vessel grafting method|
|US20060265000 *||3 May 2006||23 Nov 2006||Azizi Gholam-Reza Z||Exchange method for emboli containment|
|US20060270892 *||3 May 2006||30 Nov 2006||Bolling Steven F||Implantable heart assist system and method of applying same|
|US20060271173 *||28 Apr 2006||30 Nov 2006||Delgado Reynolds M Iii||Method and apparatus for implanting an aortic valve prosthesis|
|US20070055108 *||1 Feb 2006||8 Mar 2007||Taylor Charles S|
|US20070066943 *||21 Sep 2005||22 Mar 2007||Abiomed, Inc.||Cannula systems and methods of use|
|US20070078377 *||30 Jul 2004||5 Apr 2007||Mason Jeffrey T||Medication infusion and aspiration system and method|
|US20100217384 *||7 May 2010||26 Aug 2010||Medtronic Vascular, Inc.||Method For Replacing Native Valve Function Of A Diseased Aortic Valve|
|US20110046726 *||24 Feb 2011||Delgado Iii Reynolds M||Apparatus for Implanting an Aortic Valve Prosthesis|
|US20110152741 *||23 Jun 2011||Michael Banchieri||Cannula system|
|US20140194997 *||12 Mar 2014||10 Jul 2014||Kinamed, Inc.|
|US20140194998 *||12 Mar 2014||10 Jul 2014||Kinamed, Inc.|
|US20150057589 *||29 Apr 2014||26 Feb 2015||Neil J. Thomas||Method and Apparatus for Controlled Reoxygenation|
|USRE35352 *||19 Jan 1996||15 Oct 1996||Heartport, Inc.||Method for intraluminally inducing cardioplegic arrest and catheter for use therein|
|USRE36774||24 Apr 1997||11 Jul 2000||Baxter Healthcare Corporation||Cylindrical blood heater/oxygenator|
|DE4495438T1 *||25 Jul 1994||22 Aug 1996||Pall Corp||Kardioplegie-Filter|
|EP0983104A1 *||15 May 1998||8 Mar 2000||United States Surgical Corporation||Catheter system|
|WO1994018881A1 *||10 Jan 1994||1 Sep 1994||Stanford Surgical Technologies||Method for performing thoracoscopic cardiac bypass procedures|
|WO1995015192A1 *||10 Nov 1994||8 Jun 1995||Stanford Surgical Technologies||Cardiopulmonary bypass system for closed-chest intervention|
|WO1996017644A1||21 Nov 1995||13 Jun 1996||Heartport Inc||Cardioplegia catheter system|
|WO1996030072A1 *||11 Mar 1996||3 Oct 1996||Heartport Inc||System and methods for performing endovascular procedures|
|WO1997043899A1 *||16 May 1997||27 Nov 1997||Breonics Inc||Solution and process for resuscitation and reparation of ischemically damaged tissue|
|WO2000009200A1||26 Feb 1999||24 Feb 2000||Barbut Denise R||Intravascular methods and apparatus for isolation and selective cooling of the cerebral vasculature during surgical procedures|
|WO2008097545A2 *||5 Feb 2008||14 Aug 2008||Possis Medical Inc||Miniature flexible thrombectomy catheter|
|U.S. Classification||604/6.11, 604/8, 604/508|
|International Classification||A61M1/02, A61M1/14, A61M25/00, A61M1/10, A61M1/36|
|Cooperative Classification||A61M1/3621, A61M2205/3351, A61M2205/366, A61M1/3664, A61M2025/0003, A61M2205/3344, A61M2205/3355, A61M1/3643, A61M1/3613|
|12 Sep 1989||AS||Assignment|
Owner name: SHILEY, INC., 17600 GILLETTE AVE., IRVINE, CA 9271
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:BUCKBERG, GERALD D.;MALONEY, JAMES V. JR.;JONES, KENNETH A.;AND OTHERS;REEL/FRAME:005140/0725;SIGNING DATES FROM 19890808 TO 19890825
|29 Oct 1992||AS||Assignment|
Owner name: SORIN BIOMEDICAL INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:SHILEY INCORPORATED;REEL/FRAME:006289/0029
Effective date: 19920226
|30 Sep 1994||FPAY||Fee payment|
Year of fee payment: 4
|19 Oct 1998||FPAY||Fee payment|
Year of fee payment: 8
|13 Nov 2002||REMI||Maintenance fee reminder mailed|
|30 Apr 2003||REIN||Reinstatement after maintenance fee payment confirmed|
|11 Jun 2003||FPAY||Fee payment|
Year of fee payment: 12
|11 Jun 2003||SULP||Surcharge for late payment|
|23 Jun 2003||PRDP||Patent reinstated due to the acceptance of a late maintenance fee|
Effective date: 20030623
|24 Jun 2003||FP||Expired due to failure to pay maintenance fee|
Effective date: 20030430